125742 45 S211 M5 c4591001 interim ado mth6 demographics
Document text
16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1005 10051317/ BNT162b2 (30 μg) 12 Female 145.54 51.18 24.1 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1005 10051328/ BNT162b2 (30 μg) 14 Female 160.02 57.09 22.2 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1005 10051339/ Placebo 14 Female 161.29 54.64 21 White Non-Hispanic/non- Latino 21OCT2020 C4591001 1005 10051410/ Placebo 13 Female 152.4 35.45 15.2 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1005 10051412/ BNT162b2 (30 μg) 14 Female 157.48 93.73 37.7 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1005 10051413/ BNT162b2 (30 μg) 15 Male 193.04 105.45 28.2 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1005 10051414/ Placebo 13 Female 170.18 76.09 26.2 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1005 10051415/ Placebo 15 Male 164.59 51.45 19 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1005 10051417/ Placebo 13 Female 157.48 48.64 19.6 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1005 10051418/ BNT162b2 (30 μg) 15 Female 162.56 54.73 20.7 White Non-Hispanic/non- Latino 16DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 1 FDA-CBER-2022-5812-0224305 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1005 10051419/ Placebo 15 Female 162.56 53.91 20.4 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1005 10051420/ BNT162b2 (30 μg) 12 Female 166.37 49.09 17.7 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1005 10051421/ Placebo 13 Male 174.24 54.18 17.8 Black or African American Non-Hispanic/non- Latino 17DEC2020 C4591001 1005 10051422/ Placebo 12 Male 152.4 38.18 16.4 Black or African American Non-Hispanic/non- Latino 17DEC2020 C4591001 1005 10051424/ BNT162b2 (30 μg) 13 Male 156.21 38.09 15.6 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1005 10051425/ BNT162b2 (30 μg) 13 Female 168.15 64.45 22.7 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1005 10051427/ Placebo 14 Female 162.56 59.82 22.6 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1005 10051428/ BNT162b2 (30 μg) 15 Female 170.18 67.68 23.3 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1005 10051429/ BNT162b2 (30 μg) 14 Male 156.97 42.45 17.2 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1005 10051430/ Placebo 15 Male 185.42 71.73 20.8 White Non-Hispanic/non- Latino 22DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 2 FDA-CBER-2022-5812-0224306 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1005 10051431/ BNT162b2 (30 μg) 14 Male 180.34 98.18 30.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051436/ BNT162b2 (30 μg) 15 Female 168.91 51.55 18 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051437/ Placebo 15 Female 160.02 66.09 25.8 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051438/ Placebo 13 Male 154.69 35.91 15 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051439/ BNT162b2 (30 μg) 14 Male 180.34 74.09 22.7 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051440/ Placebo 12 Male 164.59 71 26.2 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051441/ BNT162b2 (30 μg) 15 Female 154.94 61.82 25.7 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051444/ Placebo 15 Male 170.18 79.82 27.5 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051445/ Placebo 14 Female 175.26 60.82 19.8 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1005 10051447/ BNT162b2 (30 μg) 14 Female 170.18 77.27 26.6 White Non-Hispanic/non- Latino 11JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 3 FDA-CBER-2022-5812-0224307 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1005 10051448/ Placebo 12 Female 160.02 59.45 23.2 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1005 10051449/ BNT162b2 (30 μg) 14 Male 178.31 82.82 26 White Hispanic/Latino 11JAN2021 C4591001 1005 10051450/ Placebo 14 Male 168.91 61.18 21.4 Asian Other Non-Hispanic/non- Latino 11JAN2021 C4591001 1005 10051451/ BNT162b2 (30 μg) 15 Female 153.67 41.55 17.6 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1006 10061183/ Placebo 14 Male 166.37 97.73 35.2 Multiracial Hispanic/Latino 30NOV2020 C4591001 1006 10061184/ BNT162b2 (30 μg) 15 Male 166.37 54.18 19.5 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1006 10061188/ Placebo 12 Female 152.4 45.18 19.4 Asian Non-Hispanic/non- Latino 01DEC2020 C4591001 1006 10061189/ BNT162b2 (30 μg) 15 Male 173.99 59.23 19.5 Asian Non-Hispanic/non- Latino 01DEC2020 C4591001 1006 10061190/ BNT162b2 (30 μg) 15 Male 171.45 75.45 25.6 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1006 10061191/ BNT162b2 (30 μg) 15 Female 162.56 62.73 23.7 White Hispanic/Latino 02DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 4 FDA-CBER-2022-5812-0224308 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061196/ Placebo 12 Male 167.64 57.59 20.4 White Hispanic/Latino 02DEC2020 C4591001 1006 10061200/ Placebo 15 Male 173.99 79.55 26.2 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1006 10061201/ BNT162b2 (30 μg) 12 Male 162.56 74.27 28 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1006 10061203/ BNT162b2 (30 μg) 13 Female 161.29 50.09 19.2 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1006 10061206/ Placebo 12 Male 161.29 63.59 24.4 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1006 10061207/ Placebo 14 Male 172.72 54.64 18.3 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1006 10061209/ BNT162b2 (30 μg) 13 Male 170.69 57.73 19.8 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1006 10061212/ Placebo 14 Female 161.29 49.91 19.1 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1006 10061213/ BNT162b2 (30 μg) 12 Male 166.37 52.82 19 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1006 10061214/ Placebo 14 Male 175.26 90.27 29.3 Black or African American Hispanic/Latino 04DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 5 FDA-CBER-2022-5812-0224309 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061219/ Placebo 14 Male 193.8 82.64 22 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1006 10061220/ BNT162b2 (30 μg) 15 Male 176.53 70.73 22.6 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1006 10061221/ BNT162b2 (30 μg) 15 Female 160.02 58.5 22.8 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1006 10061223/ Placebo 15 Male 152.4 37.09 15.9 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1006 10061224/ BNT162b2 (30 μg) 14 Female 160.02 68.18 26.6 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1006 10061226/ Placebo 15 Female 161.29 49.64 19 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1006 10061227/ BNT162b2 (30 μg) 15 Female 162.56 55.55 21 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1006 10061228/ Placebo 12 Female 161.29 46.73 17.9 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1006 10061229/ Placebo 15 Female 160.78 49.64 19.2 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1006 10061230/ BNT162b2 (30 μg) 14 Female 166.37 60.77 21.9 Multiracial Non-Hispanic/non- Latino 08DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 6 FDA-CBER-2022-5812-0224310 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061231/ BNT162b2 (30 μg) 12 Female 151.77 52 22.5 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1006 10061232/ Placebo 13 Female 168.91 47.45 16.6 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1006 10061233/ Placebo 15 Male 173.99 46.64 15.4 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1006 10061234/ BNT162b2 (30 μg) 13 Male 167.64 48.82 17.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1006 10061235/ Placebo 15 Male 182.88 60.18 18 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1006 10061236/ BNT162b2 (30 μg) 15 Female 156.21 49.27 20.1 Asian Non-Hispanic/non- Latino 09DEC2020 C4591001 1006 10061237/ Placebo 14 Male 170.18 66.95 23.1 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1006 10061239/ Placebo 14 Female 172.72 65.18 21.8 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1006 10061241/ BNT162b2 (30 μg) 14 Female 159.51 48.09 18.9 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1006 10061242/ BNT162b2 (30 μg) 15 Male 172.72 52.27 17.5 White Non-Hispanic/non- Latino 09DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 7 FDA-CBER-2022-5812-0224311 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061243/ BNT162b2 (30 μg) 13 Female 183.13 69.18 20.6 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1006 10061244/ BNT162b2 (30 μg) 15 Male 163.83 53.64 19.9 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1006 10061245/ Placebo 15 Male 162.56 49.36 18.6 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1006 10061247/ Placebo 13 Female 165.1 61.45 22.5 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1006 10061248/ Placebo 13 Male 166.37 51 18.4 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1006 10061249/ BNT162b2 (30 μg) 15 Female 158.75 133.09 52.7 White Hispanic/Latino 11DEC2020 C4591001 1006 10061250/ Placebo 13 Male 168.91 84.91 29.7 White Hispanic/Latino 11DEC2020 C4591001 1006 10061252/ BNT162b2 (30 μg) 14 Male 156.21 38.09 15.6 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1006 10061253/ Placebo 14 Male 180.34 63.18 19.4 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1006 10061254/ BNT162b2 (30 μg) 14 Female 165.1 95.45 34.9 White Non-Hispanic/non- Latino 11DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 8 FDA-CBER-2022-5812-0224312 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061256/ BNT162b2 (30 μg) 15 Female 163.83 70 26 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1006 10061257/ Placebo 15 Female 163.07 53.32 20 Asian Non-Hispanic/non- Latino 11DEC2020 C4591001 1006 10061258/ BNT162b2 (30 μg) 14 Male 183.39 67.64 20.1 Native Hawaiian or other Pacific Islander Non-Hispanic/non- Latino 14DEC2020 C4591001 1006 10061259/ Placebo 15 Female 163.83 45.45 16.9 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1006 10061260/ Placebo 12 Female 153.67 37.36 15.8 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1006 10061261/ BNT162b2 (30 μg) 14 Male 160.02 43.45 16.9 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1006 10061262/ Placebo 15 Male 175.51 70.55 22.9 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1006 10061263/ BNT162b2 (30 μg) 12 Female 147.32 37.55 17.3 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1006 10061264/ BNT162b2 (30 μg) 13 Male 176.53 82.36 26.4 White Hispanic/Latino 14DEC2020 C4591001 1006 10061265/ BNT162b2 (30 μg) 13 Male 154.94 36.45 15.2 White Non-Hispanic/non- Latino 15DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 9 FDA-CBER-2022-5812-0224313 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061266/ Placebo 15 Female 165.35 69 25.2 Multiracial Non-Hispanic/non- Latino 15DEC2020 C4591001 1006 10061267/ Placebo 15 Female 165.61 61.68 22.4 Asian Other Non-Hispanic/non- Latino 15DEC2020 C4591001 1006 10061269/ BNT162b2 (30 μg) 14 Male 167.64 48.09 17.1 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1006 10061270/ Placebo 15 Female 167.64 59.82 21.2 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1006 10061271/ BNT162b2 (30 μg) 14 Male 156.21 48.09 19.7 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1006 10061272/ BNT162b2 (30 μg) 13 Female 172.72 67.27 22.5 Black or African American Non-Hispanic/non- Latino 16DEC2020 C4591001 1006 10061273/ Placebo 13 Male 172.72 71.27 23.8 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1006 10061274/ BNT162b2 (30 μg) 14 Female 173.23 44.91 14.9 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1006 10061276/ Placebo 15 Female 162.56 54.73 20.7 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1006 10061277/ Placebo 13 Female 172.09 71.86 24.2 White Non-Hispanic/non- Latino 17DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 10 FDA-CBER-2022-5812-0224314 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061278/ BNT162b2 (30 μg) 13 Male 163.07 42 15.8 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1006 10061279/ Placebo 13 Female 160.02 80.73 31.5 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1006 10061280/ BNT162b2 (30 μg) 15 Male 172.72 89.73 30 White Hispanic/Latino 17DEC2020 C4591001 1006 10061282/ BNT162b2 (30 μg) 13 Male 171.45 54.09 18.4 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1006 10061283/ Placebo 15 Male 170.94 57 19.5 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1006 10061284/ Placebo 14 Male 182.88 98.27 29.3 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1006 10061285/ Placebo 14 Female 161.29 48.36 18.6 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1006 10061286/ BNT162b2 (30 μg) 14 Male 180.34 53.82 16.5 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1006 10061287/ Placebo 13 Male 165.1 47 17.2 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1006 10061288/ BNT162b2 (30 μg) 15 Female 167.64 64.36 22.9 White Non-Hispanic/non- Latino 21DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 11 FDA-CBER-2022-5812-0224315 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061289/ BNT162b2 (30 μg) 13 Female 153.67 53.64 22.7 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1006 10061290/ BNT162b2 (30 μg) 15 Female 151.13 50.55 22.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1006 10061291/ Placebo 13 Male 151.13 35.55 15.5 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1006 10061292/ Placebo 15 Female 168.91 52.27 18.3 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1006 10061293/ BNT162b2 (30 μg) 15 Male 181.61 86.36 26.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1006 10061294/ Placebo 14 Female 166.37 71.91 25.9 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1006 10061295/ Placebo 12 Male 166.37 47.45 17.1 White Non-Hispanic/non- Latino 24DEC2020 C4591001 1006 10061296/ Placebo 14 Male 173.99 51.82 17.1 White Hispanic/Latino 29DEC2020 C4591001 1006 10061297/ BNT162b2 (30 μg) 12 Female 157.48 56.5 22.7 White Hispanic/Latino 29DEC2020 C4591001 1006 10061298/ Placebo 13 Female 167.64 75.45 26.8 White Non-Hispanic/non- Latino 29DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 12 FDA-CBER-2022-5812-0224316 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1006 10061299/ BNT162b2 (30 μg) 14 Male 168.91 52.59 18.4 White Non-Hispanic/non- Latino 31DEC2020 C4591001 1006 10061300/ BNT162b2 (30 μg) 15 Male 170.18 52.45 18.1 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1007 10071409/ BNT162b2 (30 μg) 13 Male 154 36.2 15.3 Asian Non-Hispanic/non- Latino 22OCT2020 C4591001 1007 10071414/ Placebo 14 Male 166.5 46.4 16.7 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1007 10071415/ Placebo 12 Male 142 32 15.9 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1007 10071417/ BNT162b2 (30 μg) 15 Male 191.8 100.2 27.2 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1007 10071428/ Placebo 12 Male 160 41.8 16.3 Asian Non-Hispanic/non- Latino 22OCT2020 C4591001 1007 10071429/ Placebo 13 Female 159 47.7 18.9 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1007 10071467/ BNT162b2 (30 μg) 15 Female 159 55.1 21.8 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1007 10071469/ BNT162b2 (30 μg) 14 Male 126 39.6 24.9 White Non-Hispanic/non- Latino 30NOV2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 13 FDA-CBER-2022-5812-0224317 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071471/ BNT162b2 (30 μg) 14 Male 175 62.5 20.4 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1007 10071472/ Placebo 13 Female 159 50 19.8 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1007 10071475/ BNT162b2 (30 μg) 15 Female 167 57.4 20.6 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1007 10071476/ BNT162b2 (30 μg) 13 Female 159 54 21.4 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1007 10071478/ Placebo 14 Male 191 93.6 25.7 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1007 10071480/ Placebo 14 Male 175.5 95.9 31.1 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1007 10071481/ Placebo 12 Female 162 47.6 18.1 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1007 10071482/ BNT162b2 (30 μg) 13 Female 165.5 53 19.3 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1007 10071483/ Placebo 15 Female 169 50.8 17.8 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1007 10071484/ Placebo 13 Female 168.5 55.3 19.5 White Non-Hispanic/non- Latino 01DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 14 FDA-CBER-2022-5812-0224318 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071485/ BNT162b2 (30 μg) 14 Female 163.5 59.6 22.3 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1007 10071488/ BNT162b2 (30 μg) 14 Female 175 78.4 25.6 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1007 10071490/ BNT162b2 (30 μg) 13 Male 175 57.4 18.7 White Hispanic/Latino 01DEC2020 C4591001 1007 10071492/ Placebo 13 Female 157 47.7 19.4 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1007 10071494/ BNT162b2 (30 μg) 15 Male 189.5 79.1 22 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1007 10071495/ Placebo 15 Male 165 60.6 22.3 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1007 10071496/ Placebo 14 Female 167 46.2 16.6 Asian Non-Hispanic/non- Latino 02DEC2020 C4591001 1007 10071497/ BNT162b2 (30 μg) 12 Male 151 39 17.1 Asian Non-Hispanic/non- Latino 02DEC2020 C4591001 1007 10071499/ Placebo 14 Male 170 50.9 17.6 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1007 10071500/ BNT162b2 (30 μg) 15 Female 163.3 51.3 19.2 White Non-Hispanic/non- Latino 03DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 15 FDA-CBER-2022-5812-0224319 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071504/ BNT162b2 (30 μg) 15 Male 186 90.2 26.1 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071505/ Placebo 12 Female 153 53.8 23 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071506/ BNT162b2 (30 μg) 15 Female 175 69.8 22.8 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071507/ Placebo 13 Male 177.5 59.7 18.9 Asian Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071508/ BNT162b2 (30 μg) 14 Female 168 54.5 19.3 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071509/ Placebo 15 Female 162.5 71.5 27.1 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071511/ Placebo 15 Male 177 75.6 24.1 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071512/ BNT162b2 (30 μg) 15 Female 169.5 59.7 20.8 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071514/ BNT162b2 (30 μg) 12 Male 151 37.9 16.6 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1007 10071515/ Placebo 12 Male 170.5 61.7 21.2 White Non-Hispanic/non- Latino 08DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 16 FDA-CBER-2022-5812-0224320 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071516/ Placebo 15 Male 173 52.2 17.4 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071517/ BNT162b2 (30 μg) 12 Male 148 38.1 17.4 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071518/ BNT162b2 (30 μg) 15 Male 176 95.8 30.9 White Hispanic/Latino 08DEC2020 C4591001 1007 10071519/ Placebo 15 Male 177.5 65.6 20.8 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071520/ Placebo 13 Male 179 63.3 19.8 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071521/ BNT162b2 (30 μg) 13 Male 171 61.1 20.9 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071522/ Placebo 15 Female 168 74.9 26.5 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071523/ BNT162b2 (30 μg) 13 Female 148.5 40.3 18.3 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071524/ Placebo 15 Male 175 63.4 20.7 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071525/ BNT162b2 (30 μg) 13 Male 168.5 70.4 24.8 White Non-Hispanic/non- Latino 08DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 17 FDA-CBER-2022-5812-0224321 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071526/ BNT162b2 (30 μg) 14 Female 172 55 18.6 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071527/ Placebo 12 Male 168 46.7 16.5 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1007 10071528/ Placebo 14 Female 170 70 24.2 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071529/ BNT162b2 (30 μg) 14 Female 155.4 45.9 19 Multiracial Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071530/ BNT162b2 (30 μg) 12 Female 160 64.9 25.4 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071531/ Placebo 14 Female 166.5 71.4 25.8 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071533/ Placebo 14 Male 181.9 93.2 28.2 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071535/ BNT162b2 (30 μg) 15 Male 181.9 73.9 22.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071536/ BNT162b2 (30 μg) 13 Female 165 49.1 18 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071537/ BNT162b2 (30 μg) 13 Male 175 77.7 25.4 White Non-Hispanic/non- Latino 09DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 18 FDA-CBER-2022-5812-0224322 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071539/ Placebo 15 Male 164.5 47.8 17.7 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071540/ Placebo 13 Male 157 49.6 20.1 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071541/ Placebo 15 Male 172 62.6 21.2 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071542/ BNT162b2 (30 μg) 13 Female 168 59.1 20.9 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071543/ Placebo 14 Male 162 57.3 21.8 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071544/ BNT162b2 (30 μg) 12 Male 146 38 17.8 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1007 10071546/ BNT162b2 (30 μg) 15 Male 184.4 82.3 24.2 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1007 10071547/ Placebo 14 Male 171.5 59.8 20.3 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1007 10071550/ BNT162b2 (30 μg) 13 Female 163.5 40.4 15.1 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1007 10071551/ Placebo 13 Male 162 51.3 19.5 White Non-Hispanic/non- Latino 10DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 19 FDA-CBER-2022-5812-0224323 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071552/ Placebo 15 Female 167 58.7 21 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1007 10071554/ Placebo 14 Female 171 71.7 24.5 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1007 10071555/ BNT162b2 (30 μg) 12 Male 157.5 42.5 17.1 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1007 10071557/ BNT162b2 (30 μg) 15 Female 160 50.8 19.8 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071558/ BNT162b2 (30 μg) 14 Female 165.5 61.9 22.6 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071559/ Placebo 14 Female 170 62 21.5 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071560/ Placebo 12 Female 160 43 16.8 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071561/ BNT162b2 (30 μg) 12 Female 153 43 18.4 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071562/ Placebo 12 Female 161 56.7 21.9 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071563/ Placebo 12 Male 160 71.5 27.9 White Non-Hispanic/non- Latino 14DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 20 FDA-CBER-2022-5812-0224324 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071564/ BNT162b2 (30 μg) 14 Female 161 53.8 20.8 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071565/ BNT162b2 (30 μg) 14 Male 175 54 17.6 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071566/ BNT162b2 (30 μg) 15 Male 178 74.6 23.5 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1007 10071567/ BNT162b2 (30 μg) 14 Male 163 40.2 15.1 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1007 10071568/ Placebo 14 Male 170.2 63.6 22 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1007 10071569/ Placebo 12 Female 164.4 62.6 23.2 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1007 10071570/ Placebo 15 Female 168.5 103.8 36.6 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1007 10071571/ BNT162b2 (30 μg) 14 Female 160 49.3 19.3 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1007 10071572/ BNT162b2 (30 μg) 12 Female 161.3 63.2 24.3 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1007 10071573/ Placebo 12 Male 162 49.2 18.7 White Non-Hispanic/non- Latino 15DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 21 FDA-CBER-2022-5812-0224325 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071574/ BNT162b2 (30 μg) 15 Male 181 67.4 20.6 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1007 10071575/ BNT162b2 (30 μg) 15 Male 175 68.3 22.3 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1007 10071576/ Placebo 15 Female 169 53.8 18.8 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1007 10071577/ Placebo 15 Male 169 63 22.1 Multiracial Non-Hispanic/non- Latino 16DEC2020 C4591001 1007 10071578/ Placebo 12 Male 146 40.1 18.8 Multiracial Non-Hispanic/non- Latino 16DEC2020 C4591001 1007 10071579/ BNT162b2 (30 μg) 12 Female 161 42 16.2 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1007 10071580/ BNT162b2 (30 μg) 14 Female 163 55.3 20.8 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1007 10071581/ Placebo 15 Male 175 64.8 21.2 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1007 10071582/ BNT162b2 (30 μg) 12 Male 165.7 58 21.1 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1007 10071583/ Placebo 15 Male 173 87.4 29.2 White Non-Hispanic/non- Latino 17DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 22 FDA-CBER-2022-5812-0224326 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071584/ BNT162b2 (30 μg) 15 Male 188 68.7 19.4 White Hispanic/Latino 17DEC2020 C4591001 1007 10071585/ Placebo 12 Male 168 89.4 31.7 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1007 10071586/ Placebo 13 Male 165 69.1 25.4 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1007 10071587/ BNT162b2 (30 μg) 14 Female 154.9 56.3 23.5 Asian Non-Hispanic/non- Latino 17DEC2020 C4591001 1007 10071588/ BNT162b2 (30 μg) 13 Male 147 40.4 18.7 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071589/ Placebo 12 Male 145 31.7 15.1 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071590/ BNT162b2 (30 μg) 14 Male 165 59.9 22 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071591/ Placebo 13 Male 161 50.1 19.3 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071592/ BNT162b2 (30 μg) 13 Male 155 40 16.6 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071593/ Placebo 15 Male 201.7 100 24.6 White Non-Hispanic/non- Latino 28DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 23 FDA-CBER-2022-5812-0224327 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071594/ BNT162b2 (30 μg) 14 Female 174 55.7 18.4 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071595/ Placebo 13 Female 162 49.4 18.8 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071596/ Placebo 13 Male 160 36.9 14.4 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071597/ BNT162b2 (30 μg) 14 Female 159 37.2 14.7 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071599/ BNT162b2 (30 μg) 14 Male 166 42.5 15.4 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071600/ Placebo 12 Female 150 39.2 17.4 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071601/ Placebo 15 Male 176.5 65.2 20.9 Asian Other Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071602/ BNT162b2 (30 μg) 14 Male 165 47.1 17.3 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1007 10071603/ Placebo 13 Male 164 56.3 20.9 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071604/ Placebo 15 Female 172 77.1 26.1 White Non-Hispanic/non- Latino 29DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 24 FDA-CBER-2022-5812-0224328 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071605/ BNT162b2 (30 μg) 12 Male 154 38.8 16.4 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071606/ BNT162b2 (30 μg) 13 Female 151 45.2 19.8 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071607/ Placebo 14 Female 163 67.4 25.4 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071608/ Placebo 12 Male 149 36.4 16.4 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071609/ BNT162b2 (30 μg) 12 Male 162.5 56.6 21.4 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071610/ BNT162b2 (30 μg) 15 Female 161 87.8 33.9 American Indian or Alaska Native Hispanic/Latino 29DEC2020 C4591001 1007 10071612/ BNT162b2 (30 μg) 14 Male 159 47.9 18.9 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071613/ Placebo 13 Male 166.1 51.2 18.6 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071614/ Placebo 14 Male 170 56.3 19.5 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071615/ BNT162b2 (30 μg) 12 Male 155 45.9 19.1 White Non-Hispanic/non- Latino 29DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 25 FDA-CBER-2022-5812-0224329 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071616/ BNT162b2 (30 μg) 15 Male 170.5 66.5 22.9 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071617/ Placebo 15 Female 167 62.3 22.3 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071618/ Placebo 13 Male 165 60.4 22.2 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1007 10071619/ BNT162b2 (30 μg) 12 Male 155 39.5 16.4 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071620/ BNT162b2 (30 μg) 12 Female 155.5 57.1 23.6 White Hispanic/Latino 30DEC2020 C4591001 1007 10071621/ Placebo 14 Male 149 39.5 17.8 White Hispanic/Latino 30DEC2020 C4591001 1007 10071622/ BNT162b2 (30 μg) 15 Male 162 59 22.5 White Hispanic/Latino 30DEC2020 C4591001 1007 10071623/ Placebo 13 Male 163 45 16.9 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071624/ Placebo 13 Male 170 55.5 19.2 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071625/ Placebo 13 Female 167 48.3 17.3 White Non-Hispanic/non- Latino 30DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 26 FDA-CBER-2022-5812-0224330 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071626/ BNT162b2 (30 μg) 14 Male 156.5 43 17.6 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071627/ BNT162b2 (30 μg) 14 Male 182 74.6 22.5 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071628/ BNT162b2 (30 μg) 14 Male 183 55.7 16.6 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071629/ Placebo 15 Female 156 61.8 25.4 Asian Other Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071630/ Placebo 13 Male 153 51.9 22.2 Asian Other Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071631/ BNT162b2 (30 μg) 12 Male 166 57.4 20.8 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071632/ Placebo 13 Female 177 58.8 18.8 White Hispanic/Latino 30DEC2020 C4591001 1007 10071633/ BNT162b2 (30 μg) 12 Male 156 47.3 19.4 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1007 10071634/ BNT162b2 (30 μg) 14 Male 174 55.8 18.4 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071635/ Placebo 13 Male 165 50.7 18.6 White Non-Hispanic/non- Latino 04JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 27 FDA-CBER-2022-5812-0224331 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071636/ BNT162b2 (30 μg) 12 Female 162 71.6 27.3 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071638/ BNT162b2 (30 μg) 13 Female 166.5 65.9 23.8 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071639/ Placebo 13 Male 176 70.8 22.9 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071640/ Placebo 14 Female 162 48.7 18.6 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071641/ BNT162b2 (30 μg) 13 Female 168 53.4 18.9 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071642/ BNT162b2 (30 μg) 15 Male 170 45 15.6 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071643/ Placebo 12 Male 148 38.6 17.6 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071644/ BNT162b2 (30 μg) 13 Male 160 35 13.7 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071645/ Placebo 14 Male 181 70.7 21.6 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071646/ Placebo 12 Male 147 31.8 14.7 White Non-Hispanic/non- Latino 04JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 28 FDA-CBER-2022-5812-0224332 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071647/ BNT162b2 (30 μg) 12 Male 162.5 62.4 23.6 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1007 10071648/ Placebo 15 Male 176.5 60.5 19.4 Asian Other Non-Hispanic/non- Latino 05JAN2021 C4591001 1007 10071649/ BNT162b2 (30 μg) 14 Female 184 66.8 19.7 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1007 10071650/ Placebo 13 Male 159.5 77.2 30.3 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1007 10071651/ BNT162b2 (30 μg) 12 Male 160 44.6 17.4 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1007 10071652/ Placebo 12 Female 164 55 20.4 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1007 10071653/ BNT162b2 (30 μg) 14 Male 174 82.1 27.1 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1007 10071654/ Placebo 12 Female 150.2 39.8 17.6 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1007 10071655/ Placebo 14 Male 167 45.4 16.3 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1007 10071656/ BNT162b2 (30 μg) 14 Female 157.5 51.4 20.7 White Non-Hispanic/non- Latino 06JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 29 FDA-CBER-2022-5812-0224333 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1007 10071658/ Placebo 13 Female 164 68.4 25.4 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1007 10071659/ BNT162b2 (30 μg) 15 Female 153 48.8 20.8 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1007 10071660/ Placebo 12 Male 150 33.7 15 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1007 10071661/ BNT162b2 (30 μg) 13 Female 174 63.9 21.1 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1007 10071662/ Placebo 15 Female 175.5 63.6 20.6 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1008 10081751/ Placebo 13 Female 157.48 68.45 27.5 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1008 10081752/ Placebo 15 Male 167.64 56.45 20 Asian Non-Hispanic/non- Latino 01DEC2020 C4591001 1008 10081753/ BNT162b2 (30 μg) 14 Male 168.91 55 19.2 Asian Non-Hispanic/non- Latino 01DEC2020 C4591001 1008 10081754/ BNT162b2 (30 μg) 12 Male 163.83 41.91 15.6 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1008 10081755/ BNT162b2 (30 μg) 15 Female 167.64 53.82 19.1 White Non-Hispanic/non- Latino 02DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 30 FDA-CBER-2022-5812-0224334 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081756/ Placebo 15 Female 162.56 47.18 17.8 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1008 10081757/ Placebo 12 Male 165.1 47.45 17.4 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1008 10081758/ BNT162b2 (30 μg) 15 Female 160.02 70.82 27.6 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1008 10081760/ BNT162b2 (30 μg) 13 Female 166.37 62.64 22.6 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1008 10081761/ Placebo 15 Female 165.1 91.36 33.4 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1008 10081763/ Placebo 14 Male 175.26 93.45 30.4 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1008 10081764/ BNT162b2 (30 μg) 13 Female 160.02 64.64 25.2 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1008 10081767/ Placebo 15 Male 176.53 55.82 17.9 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1008 10081768/ Placebo 14 Female 171.45 56.82 19.3 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1008 10081769/ BNT162b2 (30 μg) 15 Male 174.63 50.73 16.6 White Non-Hispanic/non- Latino 08DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 31 FDA-CBER-2022-5812-0224335 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081770/ BNT162b2 (30 μg) 14 Female 175.26 59.55 19.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1008 10081771/ BNT162b2 (30 μg) 12 Female 161.29 60.36 23.2 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1008 10081773/ Placebo 13 Male 177.8 61.27 19.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1008 10081774/ BNT162b2 (30 μg) 12 Female 167.64 58 20.6 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1008 10081775/ Placebo 14 Male 165.1 49.82 18.2 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1008 10081777/ BNT162b2 (30 μg) 15 Female 170.18 47 16.2 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1008 10081780/ Placebo 15 Female 162.56 61.91 23.4 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1008 10081781/ Placebo 13 Female 149.86 55 24.4 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1008 10081785/ BNT162b2 (30 μg) 13 Female 163.83 65.55 24.4 Asian Non-Hispanic/non- Latino 11DEC2020 C4591001 1008 10081788/ Placebo 13 Female 165.1 50.36 18.4 White Non-Hispanic/non- Latino 14DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 32 FDA-CBER-2022-5812-0224336 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081789/ BNT162b2 (30 μg) 15 Male 180.34 64.91 19.9 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1008 10081790/ Placebo 12 Female 161.29 62.45 24 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1008 10081791/ BNT162b2 (30 μg) 12 Male 167.01 50.36 18 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1008 10081792/ BNT162b2 (30 μg) 13 Female 175.26 57.45 18.7 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1008 10081793/ Placebo 14 Male 189.87 70.45 19.5 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1008 10081794/ Placebo 12 Female 154.94 39.82 16.6 Asian Non-Hispanic/non- Latino 14DEC2020 C4591001 1008 10081795/ BNT162b2 (30 μg) 14 Male 172.72 57.55 19.2 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1008 10081796/ Placebo 15 Female 164.47 54.09 20 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1008 10081797/ BNT162b2 (30 μg) 14 Female 154.31 60.91 25.5 American Indian or Alaska Native Hispanic/Latino 15DEC2020 C4591001 1008 10081798/ Placebo 13 Female 149.86 41.18 18.3 White Non-Hispanic/non- Latino 15DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 33 FDA-CBER-2022-5812-0224337 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081799/ BNT162b2 (30 μg) 13 Female 161.93 62.91 23.9 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1008 10081800/ BNT162b2 (30 μg) 14 Female 167.64 47.91 17 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1008 10081801/ Placebo 15 Female 172.72 70.45 23.6 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1008 10081802/ BNT162b2 (30 μg) 13 Male 156.85 41 16.6 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1008 10081803/ Placebo 15 Male 194.31 146.64 38.8 Black or African American Non-Hispanic/non- Latino 17DEC2020 C4591001 1008 10081804/ Placebo 14 Female 157.48 51.36 20.7 Asian Non-Hispanic/non- Latino 17DEC2020 C4591001 1008 10081805/ BNT162b2 (30 μg) 12 Female 164.47 63.73 23.5 Asian Other Non-Hispanic/non- Latino 17DEC2020 C4591001 1008 10081806/ BNT162b2 (30 μg) 14 Female 173.99 56.45 18.6 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1008 10081807/ Placebo 12 Female 172.72 80.55 26.9 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1008 10081808/ Placebo 13 Male 167.01 48.82 17.5 Asian Other Non-Hispanic/non- Latino 18DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 34 FDA-CBER-2022-5812-0224338 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081809/ Placebo 13 Female 167.64 54.73 19.4 Asian Non-Hispanic/non- Latino 18DEC2020 C4591001 1008 10081810/ BNT162b2 (30 μg) 13 Female 162.56 63.27 23.9 White Hispanic/Latino 18DEC2020 C4591001 1008 10081811/ BNT162b2 (30 μg) 15 Female 154.94 62.82 26.1 White Hispanic/Latino 18DEC2020 C4591001 1008 10081812/ Placebo 14 Male 169.55 63.64 22.1 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1008 10081813/ BNT162b2 (30 μg) 12 Male 161.29 54.91 21.1 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1008 10081814/ BNT162b2 (30 μg) 13 Female 151.13 47.27 20.7 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1008 10081815/ Placebo 12 Female 167.64 59.64 21.2 Black or African American Non-Hispanic/non- Latino 18DEC2020 C4591001 1008 10081816/ BNT162b2 (30 μg) 13 Female 165.74 61 22.2 Black or African American Non-Hispanic/non- Latino 18DEC2020 C4591001 1008 10081817/ Placebo 13 Female 149.23 47.09 21.1 Asian Other Non-Hispanic/non- Latino 18DEC2020 C4591001 1008 10081818/ BNT162b2 (30 μg) 15 Male 165.1 48.55 17.8 White Non-Hispanic/non- Latino 18DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 35 FDA-CBER-2022-5812-0224339 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081819/ Placebo 12 Male 161.29 47.27 18.1 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081820/ Placebo 14 Female 173.36 58.82 19.5 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081821/ BNT162b2 (30 μg) 13 Male 157.48 41.73 16.8 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081822/ Placebo 13 Female 173.99 56 18.5 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081823/ BNT162b2 (30 μg) 14 Male 165.1 51.73 18.9 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081824/ BNT162b2 (30 μg) 12 Male 151.77 32.36 14 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081825/ Placebo 12 Female 151.77 40 17.3 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081826/ BNT162b2 (30 μg) 14 Male 170.82 58.73 20.1 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081827/ BNT162b2 (30 μg) 15 Female 180.34 55.91 17.2 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1008 10081828/ Placebo 14 Female 168.91 67.91 23.7 White Non-Hispanic/non- Latino 21DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 36 FDA-CBER-2022-5812-0224340 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081829/ Placebo 13 Male 177.17 49.73 15.8 Asian Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081830/ Placebo 13 Male 168.91 49 17.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081831/ BNT162b2 (30 μg) 15 Male 167.64 70.91 25.2 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081832/ BNT162b2 (30 μg) 15 Female 162.56 114.27 43.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081833/ Placebo 13 Male 157.48 60 24.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081834/ Placebo 13 Male 156.85 47.73 19.4 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081835/ BNT162b2 (30 μg) 14 Male 161.93 49.27 18.8 Asian Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081836/ Placebo 14 Female 169.55 65.75 22.8 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081837/ Placebo 12 Male 147.32 40.82 18.8 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081838/ BNT162b2 (30 μg) 15 Male 152.4 59 25.3 White Non-Hispanic/non- Latino 22DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 37 FDA-CBER-2022-5812-0224341 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081839/ BNT162b2 (30 μg) 15 Female 164.47 64.09 23.6 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1008 10081840/ Placebo 15 Female 166.37 59.09 21.3 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081841/ BNT162b2 (30 μg) 14 Male 176.53 76.18 24.4 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081842/ Placebo 12 Female 152.4 40.09 17.2 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081843/ BNT162b2 (30 μg) 15 Male 185.42 73.64 21.4 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081844/ Placebo 12 Male 168.91 59.55 20.8 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081845/ Placebo 13 Female 160.02 50.91 19.8 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081846/ BNT162b2 (30 μg) 15 Female 161.29 50.18 19.2 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081847/ BNT162b2 (30 μg) 14 Female 161.93 91.09 34.7 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081848/ BNT162b2 (30 μg) 13 Male 158.75 40.91 16.2 White Non-Hispanic/non- Latino 23DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 38 FDA-CBER-2022-5812-0224342 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081849/ Placebo 12 Male 162.56 47 17.7 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081850/ BNT162b2 (30 μg) 15 Female 153.67 48.18 20.4 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081851/ Placebo 13 Female 165.1 53.82 19.7 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081852/ Placebo 15 Male 193.04 100.73 27 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1008 10081853/ Placebo 14 Female 168.28 57.45 20.2 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1008 10081854/ BNT162b2 (30 μg) 15 Male 164.47 42.73 15.8 Asian Other Non-Hispanic/non- Latino 28DEC2020 C4591001 1008 10081855/ BNT162b2 (30 μg) 14 Male 164.47 53.18 19.6 Asian Other Non-Hispanic/non- Latino 28DEC2020 C4591001 1008 10081856/ Placebo 14 Female 157.48 53.55 21.5 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1008 10081857/ BNT162b2 (30 μg) 13 Female 156.21 45.09 18.4 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1008 10081858/ Placebo 15 Male 170.18 64.36 22.2 White Non-Hispanic/non- Latino 28DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 39 FDA-CBER-2022-5812-0224343 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081859/ BNT162b2 (30 μg) 15 Female 168.91 68.18 23.8 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1008 10081860/ BNT162b2 (30 μg) 14 Male 168.28 62 21.8 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1008 10081861/ Placebo 14 Male 167.64 52.82 18.8 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1008 10081862/ BNT162b2 (30 μg) 12 Female 168.28 54.09 19.1 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1008 10081863/ Placebo 13 Female 160.02 42.82 16.7 Asian Other Non-Hispanic/non- Latino 29DEC2020 C4591001 1008 10081864/ BNT162b2 (30 μg) 12 Female 148.59 34.73 15.7 Asian Other Non-Hispanic/non- Latino 29DEC2020 C4591001 1008 10081865/ BNT162b2 (30 μg) 13 Female 163.2 55.73 20.9 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1008 10081866/ Placebo 13 Male 156.21 51.55 21.1 White Hispanic/Latino 29DEC2020 C4591001 1008 10081867/ Placebo 13 Female 160.02 50.64 19.7 White Hispanic/Latino 29DEC2020 C4591001 1008 10081868/ BNT162b2 (30 μg) 15 Female 165.1 61.91 22.7 White Non-Hispanic/non- Latino 29DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 40 FDA-CBER-2022-5812-0224344 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081869/ Placebo 14 Female 166.37 68.27 24.6 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1008 10081870/ BNT162b2 (30 μg) 14 Male 157.48 58 23.3 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1008 10081871/ Placebo 14 Female 180.34 77.64 23.8 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1008 10081872/ Placebo 15 Male 173.99 50.55 16.7 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1008 10081873/ BNT162b2 (30 μg) 13 Female 157.48 63.36 25.5 Black or African American Hispanic/Latino 30DEC2020 C4591001 1008 10081874/ BNT162b2 (30 μg) 12 Male 165.1 78 28.6 White Hispanic/Latino 30DEC2020 C4591001 1008 10081875/ Placebo 15 Female 170.18 59.36 20.5 White Hispanic/Latino 30DEC2020 C4591001 1008 10081876/ BNT162b2 (30 μg) 12 Male 154.31 36.64 15.4 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1008 10081877/ Placebo 14 Male 179.07 63 19.6 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1008 10081878/ BNT162b2 (30 μg) 15 Female 168.28 62.73 22.1 White Non-Hispanic/non- Latino 30DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 41 FDA-CBER-2022-5812-0224345 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081879/ Placebo 14 Male 161.93 76.18 29 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1008 10081880/ Placebo 14 Female 163.83 48.73 18.1 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1008 10081881/ Placebo 12 Female 167.64 49.55 17.6 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1008 10081882/ BNT162b2 (30 μg) 15 Male 190.5 74.36 20.4 White Non-Hispanic/non- Latino 31DEC2020 C4591001 1008 10081883/ BNT162b2 (30 μg) 15 Female 172.09 68.45 23.1 White Non-Hispanic/non- Latino 31DEC2020 C4591001 1008 10081884/ Placebo 15 Female 161.29 106.41 40.8 White Non-Hispanic/non- Latino 31DEC2020 C4591001 1008 10081885/ BNT162b2 (30 μg) 14 Male 149.86 36.55 16.2 White Hispanic/Latino 31DEC2020 C4591001 1008 10081886/ BNT162b2 (30 μg) 12 Female 144.78 29 13.8 White Hispanic/Latino 31DEC2020 C4591001 1008 10081887/ Placebo 12 Female 165.1 43.91 16.1 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1008 10081888/ Placebo 14 Male 174.63 59.91 19.6 White Non-Hispanic/non- Latino 04JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 42 FDA-CBER-2022-5812-0224346 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081889/ BNT162b2 (30 μg) 14 Female 181.61 78.36 23.7 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1008 10081890/ BNT162b2 (30 μg) 13 Male 182.88 90.91 27.1 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1008 10081891/ Placebo 14 Male 165.74 56.27 20.4 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1008 10081892/ Placebo 14 Male 163.2 70.45 26.4 American Indian or Alaska Native Hispanic/Latino 04JAN2021 C4591001 1008 10081893/ BNT162b2 (30 μg) 14 Female 160.02 66.18 25.8 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1008 10081894/ BNT162b2 (30 μg) 13 Female 172.72 56.27 18.8 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1008 10081895/ BNT162b2 (30 μg) 14 Female 157.48 40.91 16.5 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1008 10081896/ Placebo 15 Male 188.6 84.91 23.8 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1008 10081897/ BNT162b2 (30 μg) 13 Female 160.02 44.45 17.3 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1008 10081898/ Placebo 12 Female 160.02 56.09 21.9 White Non-Hispanic/non- Latino 05JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 43 FDA-CBER-2022-5812-0224347 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081899/ Placebo 15 Female 167.64 68.36 24.3 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1008 10081900/ BNT162b2 (30 μg) 13 Female 169.55 72.18 25.1 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1008 10081901/ Placebo 15 Male 178.44 90.45 28.3 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1008 10081902/ Placebo 14 Male 177.8 67.45 21.3 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1008 10081903/ BNT162b2 (30 μg) 12 Male 147.32 38.64 17.8 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1008 10081904/ Placebo 12 Male 168.28 82 28.9 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1008 10081905/ BNT162b2 (30 μg) 15 Female 180.98 59.45 18.1 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081906/ BNT162b2 (30 μg) 14 Female 158.75 58.64 23.2 Asian Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081907/ Placebo 14 Female 157.48 59.09 23.8 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081908/ BNT162b2 (30 μg) 12 Female 167.64 53.45 19 White Non-Hispanic/non- Latino 06JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 44 FDA-CBER-2022-5812-0224348 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081909/ Placebo 14 Male 170.18 54.18 18.7 Asian Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081910/ BNT162b2 (30 μg) 14 Male 171.45 54.91 18.6 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081911/ Placebo 14 Male 154.94 47.73 19.8 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081912/ BNT162b2 (30 μg) 12 Male 152.4 57.09 24.5 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081913/ Placebo 13 Male 171.45 54.45 18.5 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081914/ Placebo 14 Male 176.53 94.45 30.2 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1008 10081915/ BNT162b2 (30 μg) 13 Female 149.86 57.64 25.6 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1008 10081916/ BNT162b2 (30 μg) 15 Male 180.34 85.45 26.2 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1008 10081917/ Placebo 13 Male 174.63 71.27 23.3 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1008 10081918/ BNT162b2 (30 μg) 12 Female 147.32 39.36 18.1 White Non-Hispanic/non- Latino 07JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 45 FDA-CBER-2022-5812-0224349 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081919/ Placebo 14 Female 160.66 52.82 20.4 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1008 10081920/ BNT162b2 (30 μg) 13 Female 166.37 59.36 21.4 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1008 10081921/ Placebo 15 Male 186.69 64.82 18.6 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1008 10081922/ BNT162b2 (30 μg) 12 Male 151.13 46 20.1 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1008 10081923/ Placebo 12 Female 162.56 42.09 15.9 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1008 10081924/ Placebo 12 Female 160.02 41.27 16.1 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1008 10081925/ BNT162b2 (30 μg) 13 Female 162.56 55.91 21.1 Black or African American Non-Hispanic/non- Latino 08JAN2021 C4591001 1008 10081926/ Placebo 14 Female 162.56 47.27 17.8 Asian Other Non-Hispanic/non- Latino 08JAN2021 C4591001 1008 10081927/ BNT162b2 (30 μg) 14 Female 161.93 44.09 16.8 Asian Other Non-Hispanic/non- Latino 08JAN2021 C4591001 1008 10081928/ BNT162b2 (30 μg) 13 Female 163.83 74.09 27.5 White Non-Hispanic/non- Latino 08JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 46 FDA-CBER-2022-5812-0224350 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081929/ BNT162b2 (30 μg) 12 Female 151.13 41.55 18.1 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1008 10081930/ Placebo 12 Female 160.02 42.09 16.4 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1008 10081931/ Placebo 12 Male 157.48 55.5 22.3 Asian Non-Hispanic/non- Latino 11JAN2021 C4591001 1008 10081932/ Placebo 14 Female 157.48 52.09 21 Asian Non-Hispanic/non- Latino 11JAN2021 C4591001 1008 10081933/ Placebo 12 Male 165.1 49.36 18.1 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1008 10081934/ BNT162b2 (30 μg) 13 Female 145.42 36.64 17.3 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1008 10081935/ BNT162b2 (30 μg) 15 Male 167.64 72.73 25.8 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1008 10081936/ Placebo 14 Male 165.1 54.09 19.8 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1008 10081937/ BNT162b2 (30 μg) 13 Female 161.29 51.73 19.8 Asian Other Non-Hispanic/non- Latino 11JAN2021 C4591001 1008 10081938/ Placebo 15 Female 171.45 69.18 23.5 White Non-Hispanic/non- Latino 11JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 47 FDA-CBER-2022-5812-0224351 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1008 10081940/ BNT162b2 (30 μg) 14 Male 172.09 70.73 23.8 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1008 10081941/ Placebo 12 Female 155.58 41 16.9 Asian Non-Hispanic/non- Latino 12JAN2021 C4591001 1008 10081942/ Placebo 15 Male 178.44 70.09 22 Asian Non-Hispanic/non- Latino 12JAN2021 C4591001 1008 10081943/ BNT162b2 (30 μg) 15 Male 180.34 63.45 19.5 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1009 10091204/ Placebo 13 Male 171.45 51.18 17.4 White Non-Hispanic/non- Latino 15OCT2020 C4591001 1009 10091205/ BNT162b2 (30 μg) 15 Male 160.02 52.55 20.5 White Non-Hispanic/non- Latino 15OCT2020 C4591001 1009 10091208/ Placebo 15 Male 184.15 53.91 15.9 White Non-Hispanic/non- Latino 15OCT2020 C4591001 1009 10091209/ BNT162b2 (30 μg) 13 Female 149.86 43.27 19.2 White Non-Hispanic/non- Latino 15OCT2020 C4591001 1009 10091212/ Placebo 13 Female 151.13 41.73 18.2 White Non-Hispanic/non- Latino 16OCT2020 C4591001 1009 10091213/ Placebo 15 Male 179.07 58.55 18.2 White Non-Hispanic/non- Latino 16OCT2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 48 FDA-CBER-2022-5812-0224352 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091216/ BNT162b2 (30 μg) 12 Female 160.02 56.18 21.9 White Non-Hispanic/non- Latino 16OCT2020 C4591001 1009 10091218/ BNT162b2 (30 μg) 13 Female 162.56 59.91 22.6 White Non-Hispanic/non- Latino 16OCT2020 C4591001 1009 10091220/ Placebo 15 Male 179.58 53.18 16.5 White Non-Hispanic/non- Latino 19OCT2020 C4591001 1009 10091221/ BNT162b2 (30 μg) 14 Female 162.56 47.73 18 White Non-Hispanic/non- Latino 19OCT2020 C4591001 1009 10091223/ BNT162b2 (30 μg) 14 Male 161.29 70.91 27.2 White Non-Hispanic/non- Latino 19OCT2020 C4591001 1009 10091226/ Placebo 15 Male 172.72 73.64 24.6 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1009 10091227/ BNT162b2 (30 μg) 15 Male 172.72 58.18 19.5 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1009 10091229/ Placebo 12 Female 166.37 57 20.5 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1009 10091231/ BNT162b2 (30 μg) 15 Male 167.64 57.82 20.5 Asian Non-Hispanic/non- Latino 20OCT2020 C4591001 1009 10091233/ Placebo 12 Male 151.13 34.09 14.9 White Non-Hispanic/non- Latino 21OCT2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 49 FDA-CBER-2022-5812-0224353 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091234/ BNT162b2 (30 μg) 13 Male 162.56 50.64 19.1 White Hispanic/Latino 21OCT2020 C4591001 1009 10091237/ Placebo 14 Female 157.48 60.36 24.3 White Non-Hispanic/non- Latino 21OCT2020 C4591001 1009 10091238/ Placebo 15 Male 180.34 65.91 20.2 White Non-Hispanic/non- Latino 21OCT2020 C4591001 1009 10091240/ BNT162b2 (30 μg) 13 Male 162.56 68.64 25.9 White Non-Hispanic/non- Latino 21OCT2020 C4591001 1009 10091246/ Placebo 13 Male 157.48 35 14.1 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1009 10091247/ BNT162b2 (30 μg) 12 Male 170.18 70.18 24.2 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1009 10091249/ Placebo 15 Female 158.75 70.91 28.1 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1009 10091250/ BNT162b2 (30 μg) 13 Female 161.29 54.09 20.7 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1009 10091265/ BNT162b2 (30 μg) 14 Male 181.61 119.27 36.1 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1009 10091266/ Placebo 15 Female 165.1 77.55 28.4 White Non-Hispanic/non- Latino 01DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 50 FDA-CBER-2022-5812-0224354 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091267/ Placebo 13 Male 144.78 49.82 23.7 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1009 10091269/ BNT162b2 (30 μg) 15 Male 172.72 55.36 18.5 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1009 10091270/ BNT162b2 (30 μg) 12 Male 157.48 49.55 19.9 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1009 10091272/ BNT162b2 (30 μg) 12 Male 160.02 43.18 16.8 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1009 10091273/ Placebo 15 Male 167.64 40.36 14.3 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1009 10091274/ Placebo 12 Male 152.4 41.82 18 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1009 10091275/ Placebo 15 Male 180.34 63.73 19.6 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1009 10091277/ Placebo 13 Male 166.37 82.27 29.7 White Hispanic/Latino 03DEC2020 C4591001 1009 10091280/ BNT162b2 (30 μg) 12 Female 157.48 40.55 16.3 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1009 10091281/ BNT162b2 (30 μg) 14 Male 163.83 42.73 15.9 White Non-Hispanic/non- Latino 03DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 51 FDA-CBER-2022-5812-0224355 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091282/ Placebo 14 Male 180.34 65.45 20.1 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1009 10091283/ Placebo 13 Female 166.37 55.27 19.9 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1009 10091284/ BNT162b2 (30 μg) 15 Male 179.07 58.55 18.2 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1009 10091287/ BNT162b2 (30 μg) 15 Female 172.72 47.27 15.8 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1009 10091288/ BNT162b2 (30 μg) 13 Male 162.56 49.09 18.5 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1009 10091289/ BNT162b2 (30 μg) 13 Female 165.1 60.45 22.1 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1009 10091292/ Placebo 15 Male 175.26 62.55 20.3 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1009 10091293/ Placebo 14 Male 158.12 45.55 18.2 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1009 10091294/ Placebo 15 Female 170.18 51.55 17.8 White Hispanic/Latino 07DEC2020 C4591001 1009 10091295/ BNT162b2 (30 μg) 12 Female 144.78 28.73 13.7 White Non-Hispanic/non- Latino 07DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 52 FDA-CBER-2022-5812-0224356 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091296/ Placebo 14 Male 171.45 58.73 19.9 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1009 10091297/ BNT162b2 (30 μg) 14 Male 157.48 51.82 20.8 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1009 10091298/ BNT162b2 (30 μg) 14 Male 170.18 66.91 23.1 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1009 10091300/ BNT162b2 (30 μg) 13 Male 163.32 55.36 20.7 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1009 10091301/ Placebo 15 Female 165.74 58.64 21.3 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1009 10091303/ Placebo 13 Female 162.56 48.55 18.3 White Hispanic/Latino 08DEC2020 C4591001 1009 10091304/ BNT162b2 (30 μg) 13 Male 165.74 53.36 19.4 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1009 10091305/ Placebo 15 Female 170.18 61.27 21.1 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1009 10091306/ Placebo 14 Female 170.18 62.82 21.6 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1009 10091307/ BNT162b2 (30 μg) 15 Female 165.1 97 35.5 White Non-Hispanic/non- Latino 09DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 53 FDA-CBER-2022-5812-0224357 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091308/ Placebo 13 Male 166.37 43.36 15.6 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091309/ BNT162b2 (30 μg) 13 Male 160.02 52.45 20.4 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091310/ BNT162b2 (30 μg) 15 Female 162.56 61.64 23.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091311/ Placebo 13 Male 168.91 34.18 12 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091312/ Placebo 12 Male 157.48 45.91 18.5 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091313/ BNT162b2 (30 μg) 15 Male 172.72 73.91 24.7 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091314/ Placebo 15 Male 180.34 60.64 18.6 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091315/ BNT162b2 (30 μg) 13 Male 180.34 63.36 19.4 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091316/ Placebo 15 Male 177.8 66.82 21.1 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1009 10091317/ Placebo 13 Female 153.67 67.45 28.5 White Non-Hispanic/non- Latino 10DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 54 FDA-CBER-2022-5812-0224358 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091318/ BNT162b2 (30 μg) 14 Female 170.18 52 17.9 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1009 10091319/ BNT162b2 (30 μg) 15 Male 175.9 52.55 16.9 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1009 10091320/ Placebo 14 Male 168.91 61.18 21.4 White Hispanic/Latino 10DEC2020 C4591001 1009 10091321/ BNT162b2 (30 μg) 12 Female 161.29 48.18 18.5 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1009 10091322/ BNT162b2 (30 μg) 12 Male 154.94 42.36 17.6 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1009 10091323/ Placebo 15 Female 166.37 61.64 22.2 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1009 10091324/ Placebo 15 Female 177.8 71.73 22.6 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091325/ BNT162b2 (30 μg) 12 Male 161.29 42.27 16.2 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091326/ Placebo 12 Female 167.64 47.64 16.9 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091328/ BNT162b2 (30 μg) 13 Female 149.86 44 19.5 White Non-Hispanic/non- Latino 11DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 55 FDA-CBER-2022-5812-0224359 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091329/ Placebo 13 Female 154.94 57.82 24 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091330/ Placebo 13 Female 154.94 49.09 20.4 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091331/ BNT162b2 (30 μg) 13 Female 167.64 61.91 22 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091332/ BNT162b2 (30 μg) 15 Female 181.61 84.45 25.5 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091333/ BNT162b2 (30 μg) 14 Male 175.26 71.73 23.3 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091334/ Placebo 13 Female 149.86 47.18 21 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091335/ BNT162b2 (30 μg) 15 Female 169.55 59.09 20.5 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091336/ Placebo 13 Male 158.24 49.09 19.6 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1009 10091337/ Placebo 12 Male 158.75 45.64 18.1 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1009 10091338/ Placebo 15 Female 171.45 52 17.7 White Non-Hispanic/non- Latino 14DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 56 FDA-CBER-2022-5812-0224360 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091339/ BNT162b2 (30 μg) 14 Female 166.37 56.82 20.5 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1009 10091340/ BNT162b2 (30 μg) 15 Female 165.1 107.36 39.3 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1009 10091341/ Placebo 13 Male 153.67 38 16.1 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1009 10091342/ BNT162b2 (30 μg) 15 Male 175.26 61.64 20 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1009 10091343/ BNT162b2 (30 μg) 13 Female 142.24 40.45 20 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1009 10091344/ Placebo 15 Male 175.26 65.91 21.4 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1009 10091345/ BNT162b2 (30 μg) 12 Male 153.67 58 24.5 Multiracial Non-Hispanic/non- Latino 15DEC2020 C4591001 1009 10091346/ Place bo 15 Male 172.72 79.55 26.6 Multiracial Non-Hispanic/non- Latino 15DEC2020 C4591001 1009 10091347/ Placebo 13 Female 160.02 51.45 20.1 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1009 10091348/ BNT162b2 (30 μg) 14 Female 162.56 59.18 22.3 White Non-Hispanic/non- Latino 15DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 57 FDA-CBER-2022-5812-0224361 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091349/ Placebo 15 Female 160.02 56.73 22.1 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1009 10091350/ Placebo 14 Female 160.02 71.27 27.8 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1009 10091351/ BNT162b2 (30 μg) 12 Female 154.94 40.82 17 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1009 10091353/ BNT162b2 (30 μg) 12 Female 149.86 46.36 20.6 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1009 10091354/ BNT162b2 (30 μg) 14 Female 167.64 54.45 19.3 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1009 10091355/ BNT162b2 (30 μg) 12 Male 151.13 40.36 17.6 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1009 10091356/ Placebo 13 Female 165.61 41.64 15.1 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1009 10091357/ Placebo 15 Male 187.96 101.36 28.6 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091358/ BNT162b2 (30 μg) 14 Female 158.75 44.55 17.6 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091359/ Placebo 13 Male 156.97 54.64 22.1 White Non-Hispanic/non- Latino 17DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 58 FDA-CBER-2022-5812-0224362 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091360/ BNT162b2 (30 μg) 15 Female 156.21 67 27.4 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091361/ Placebo 13 Female 165.1 62.91 23 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091362/ BNT162b2 (30 μg) 12 Male 172.72 53.27 17.8 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091363/ Placebo 14 Male 185.42 62.36 18.1 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091364/ BNT162b2 (30 μg) 12 Female 162.56 83.09 31.4 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091365/ Placebo 12 Male 167.64 60.18 21.4 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091366/ Placebo 14 Female 170.82 72.18 24.7 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1009 10091369/ Placebo 12 Female 167.64 52 18.5 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1009 10091370/ BNT162b2 (30 μg) 13 Female 168.91 48.27 16.9 White Hispanic/Latino 18DEC2020 C4591001 1009 10091371/ BNT162b2 (30 μg) 13 Male 167.64 61.45 21.8 White Non-Hispanic/non- Latino 18DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 59 FDA-CBER-2022-5812-0224363 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091372/ BNT162b2 (30 μg) 13 Male 167.64 64.73 23 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1009 10091373/ Placebo 14 Female 154.94 52.82 22 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1009 10091374/ Placebo 15 Male 153.67 60.55 25.6 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1009 10091375/ BNT162b2 (30 μg) 13 Female 166.37 60.36 21.8 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1009 10091376/ BNT162b2 (30 μg) 12 Male 168.91 90.45 31.6 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1009 10091377/ BNT162b2 (30 μg) 12 Male 160.02 47.82 18.6 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1009 10091378/ Placebo 14 Female 162.56 49.55 18.7 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1009 10091379/ Placebo 13 Female 157.48 42.64 17.2 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1009 10091380/ Placebo 14 Male 172.72 60.09 20.1 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1009 10091381/ BNT162b2 (30 μg) 12 Female 151.13 39.36 17.2 White Non-Hispanic/non- Latino 31DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 60 FDA-CBER-2022-5812-0224364 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091382/ Placebo 14 Female 160.02 71 27.7 White Hispanic/Latino 04JAN2021 C4591001 1009 10091383/ BNT162b2 (30 μg) 15 Male 163.83 53.73 20 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1009 10091384/ Placebo 15 Female 167.64 51.73 18.4 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1009 10091385/ Placebo 14 Male 158.24 70.27 28 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1009 10091386/ BNT162b2 (30 μg) 14 Male 166.37 51.55 18.6 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1009 10091387/ BNT162b2 (30 μg) 12 Male 173.99 57.64 19 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1009 10091388/ Placebo 13 Male 149.86 43 19.1 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1009 10091389/ BNT162b2 (30 μg) 15 Male 165.1 58.73 21.5 White Hispanic/Latino 06JAN2021 C4591001 1009 10091390/ Placebo 14 Female 162.56 56.55 21.4 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1009 10091391/ BNT162b2 (30 μg) 14 Male 170.18 52 17.9 White Non-Hispanic/non- Latino 07JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 61 FDA-CBER-2022-5812-0224365 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091392/ Placebo 12 Female 156.21 50.82 20.8 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1009 10091393/ BNT162b2 (30 μg) 14 Male 171.45 59.45 20.2 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1009 10091394/ BNT162b2 (30 μg) 15 Male 170.18 58.45 20.1 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1009 10091395/ Placebo 13 Male 161.29 46.27 17.7 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1009 10091396/ BNT162b2 (30 μg) 15 Male 167.64 55.73 19.8 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1009 10091398/ BNT162b2 (30 μg) 15 Female 160.02 48.45 18.9 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1009 10091399/ Placebo 12 Female 152.4 38.86 16.7 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1009 10091400/ Placebo 12 Male 154.31 41.64 17.4 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1009 10091401/ Placebo 12 Male 151.13 40.18 17.6 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1009 10091402/ BNT162b2 (30 μg) 14 Female 157.48 42.36 17 White Hispanic/Latino 08JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 62 FDA-CBER-2022-5812-0224366 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091403/ Placebo 15 Female 179.07 102.55 31.9 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1009 10091404/ BNT162b2 (30 μg) 12 Female 149.86 40.32 17.9 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1009 10091405/ Placebo 15 Female 160.02 50 19.5 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1009 10091406/ Placebo 15 Male 173.99 53.18 17.5 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1009 10091407/ BNT162b2 (30 μg) 13 Female 167.64 50.64 18 Asian Other Non-Hispanic/non- Latino 11JAN2021 C4591001 1009 10091408/ BNT162b2 (30 μg) 13 Female 166.37 42.45 15.3 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1009 10091409/ BNT162b2 (30 μg) 14 Female 172.72 50 16.7 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1009 10091410/ BNT162b2 (30 μg) 12 Female 161.29 45.36 17.4 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1009 10091411/ Placebo 15 Male 171.45 50.82 17.3 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1009 10091412/ Placebo 15 Male 165.1 52.27 19.1 White Non-Hispanic/non- Latino 12JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 63 FDA-CBER-2022-5812-0224367 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1009 10091413/ BNT162b2 (30 μg) 13 Female 156.21 50.91 20.8 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1009 10091414/ BNT162b2 (30 μg) 14 Female 176.53 61.91 19.8 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1013 10131821/ BNT162b2 (30 μg) 14 Male 164.7 74.8 27.6 Black or African American Non-Hispanic/non- Latino 30NOV2020 C4591001 1013 10131822/ BNT162b2 (30 μg) 15 Female 160 54.8 21.4 Black or African American Non-Hispanic/non- Latino 30NOV2020 C4591001 1013 10131823/ Placebo 15 Female 160 118.2 46.2 Black or African American Non-Hispanic/non- Latino 01DEC2020 C4591001 1013 10131824/ BNT162b2 (30 μg) 14 Female 157.5 54.5 22 Black or African American Non-Hispanic/non- Latino 01DEC2020 C4591001 1013 10131826/ Placebo 14 Male 167.6 56.2 20 White Hispanic/Latino 01DEC2020 C4591001 1013 10131828/ BNT162b2 (30 μg) 14 Male 162.5 47 17.8 White Hispanic/Latino 02DEC2020 C4591001 1013 10131830/ Placebo 14 Female 172.1 57.2 19.3 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1013 10131835/ Placebo 14 Female 161.5 50.7 19.4 Black or African American Non-Hispanic/non- Latino 02DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 64 FDA-CBER-2022-5812-0224368 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1013 10131836/ BNT162b2 (30 μg) 12 Female 154 77.7 32.8 Black or African American Non-Hispanic/non- Latino 02DEC2020 C4591001 1013 10131839/ Placebo 14 Female 167.6 53.35 19 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1013 10131841/ BNT162b2 (30 μg) 13 Female 163 64.4 24.2 Black or African American Non-Hispanic/non- Latino 02DEC2020 C4591001 1013 10131842/ Placebo 15 Female 157.5 51.9 20.9 Black or African American Non-Hispanic/non- Latino 02DEC2020 C4591001 1013 10131843/ BNT162b2 (30 μg) 14 Male 179.1 72 22.4 Black or African American Non-Hispanic/non- Latino 02DEC2020 C4591001 1013 10131844/ Placebo 13 Male 164 69.15 25.7 Black or African American Non-Hispanic/non- Latino 02DEC2020 C4591001 1013 10131845/ BNT162b2 (30 μg) 12 Female 157.4 55.3 22.3 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1013 10131846/ BNT162b2 (30 μg) 15 Male 178.4 76.9 24.2 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1013 10131848/ Placebo 12 Male 175.2 55 17.9 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1013 10131850/ BNT162b2 (30 μg) 15 Female 170.1 75.8 26.2 White Non-Hispanic/non- Latino 03DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 65 FDA-CBER-2022-5812-0224369 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1013 10131851/ Placebo 15 Female 164 58.6 21.8 Multiracial Non-Hispanic/non- Latino 07DEC2020 C4591001 1013 10131852/ Placebo 14 Female 162.5 52.6 19.9 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1013 10131855/ BNT162b2 (30 μg) 14 Male 162 52.05 19.8 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1013 10131856/ BNT162b2 (30 μg) 15 Male 180.5 71.05 21.8 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1013 10131858/ Placebo 13 Female 154.3 40.8 17.1 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1013 10131859/ BNT162b2 (30 μg) 15 Male 171.1 50.5 17.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1013 10131860/ Placebo 13 Male 171.5 72.6 24.7 White Hispanic/Latino 09DEC2020 C4591001 1013 10131861/ Placebo 12 Male 153.4 39.6 16.8 Black or African American Non-Hispanic/non- Latino 10DEC2020 C4591001 1013 10131862/ BNT162b2 (30 μg) 13 Female 162.5 68 25.8 White Hispanic/Latino 10DEC2020 C4591001 1013 10131863/ Placebo 14 Female 164.8 48.5 17.9 White Non-Hispanic/non- Latino 10DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 66 FDA-CBER-2022-5812-0224370 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1013 10131865/ BNT162b2 (30 μg) 13 Male 175.6 93.2 30.2 White Hispanic/Latino 14DEC2020 C4591001 1013 10131866/ BNT162b2 (30 μg) 15 Male 175.3 86.2 28.1 White Hispanic/Latino 14DEC2020 C4591001 1013 10131867/ Placebo 12 Male 152.4 40.8 17.6 Black or African American Non-Hispanic/non- Latino 17DEC2020 C4591001 1013 10131868/ Placebo 13 Female 166 53.9 19.6 Multiracial Other Non-Hispanic/non- Latino 21DEC2020 C4591001 1013 10131869/ Placebo 14 Male 162 45.8 17.5 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1013 10131870/ Placebo 15 Male 171 64.3 22 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1013 10131871/ BNT162b2 (30 μg) 13 Male 161.6 47.6 18.2 Multiracial Non-Hispanic/non- Latino 21DEC2020 C4591001 1013 10131872/ BNT162b2 (30 μg) 12 Male 154.9 38.2 15.9 Multiracial Hispanic/Latino 21DEC2020 C4591001 1013 10131873/ BNT162b2 (30 μg) 13 Female 154 71 29.9 Asian Other Non-Hispanic/non- Latino 22DEC2020 C4591001 1013 10131874/ Placebo 12 Male 165 72 26.4 Asian Other Non-Hispanic/non- Latino 22DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 67 FDA-CBER-2022-5812-0224371 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1013 10131875/ Placebo 14 Male 160 49.8 19.5 Multiracial Other Non-Hispanic/non- Latino 22DEC2020 C4591001 1013 10131876/ BNT162b2 (30 μg) 15 Female 155 44.6 18.6 Asian Other Non-Hispanic/non- Latino 22DEC2020 C4591001 1013 10131877/ BNT162b2 (30 μg) 13 Male 162 65.15 24.8 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1013 10131878/ Placebo 12 Male 149.9 46 20.5 White Hispanic/Latino 23DEC2020 C4591001 1013 10131879/ Placebo 15 Male 178.3 54.7 17.2 White Hispanic/Latino 23DEC2020 C4591001 1013 10131880/ BNT162b2 (30 μg) 14 Male 164.2 75.2 27.9 White Hispanic/Latino 23DEC2020 C4591001 1013 10131881/ BNT162b2 (30 μg) 14 Male 170.4 53.8 18.5 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1013 10131882/ Placebo 15 Male 184 73.7 21.8 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1013 10131883/ Placebo 14 Female 157.7 40.5 16.3 White Non-Hispanic/non- Latino 31DEC2020 C4591001 1013 10131884/ BNT162b2 (30 μg) 14 Female 160 50 19.5 Asian Other Non-Hispanic/non- Latino 07JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 68 FDA-CBER-2022-5812-0224372 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1013 10131885/ Placebo 14 Female 160 43.9 17.1 White Hispanic/Latino 07JAN2021 C4591001 1013 10131886/ Placebo 12 Male 158.3 49.6 19.8 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1016 10161307/ Placebo 13 Female 160.02 128.64 50.1 Black or African American Non-Hispanic/non- Latino 15OCT2020 C4591001 1016 10161308/ Placebo 13 Male 175.26 51.91 16.9 White Non-Hispanic/non- Latino 15OCT2020 C4591001 1016 10161309/ BNT162b2 (30 μg) 14 Male 179.07 60.91 19 White Non-Hispanic/non- Latino 15OCT2020 C4591001 1016 10161310/ BNT162b2 (30 μg) 13 Male 165.1 60.82 22.3 White Non-Hispanic/non- Latino 15OCT2020 C4591001 1016 10161311/ BNT162b2 (30 μg) 15 Male 168.91 87.73 30.7 White Hispanic/Latino 15OCT2020 C4591001 1016 10161314/ BNT162b2 (30 μg) 13 Female 152.4 52.18 22.4 White Non-Hispanic/non- Latino 16OCT2020 C4591001 1016 10161315/ Placebo 14 Female 158.75 57.05 22.6 White Non-Hispanic/non- Latino 16OCT2020 C4591001 1016 10161316/ Placebo 15 Male 175.77 70 22.6 White Non-Hispanic/non- Latino 16OCT2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 69 FDA-CBER-2022-5812-0224373 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1016 10161318/ Placebo 14 Male 161.29 71 27.2 White Non-Hispanic/non- Latino 16OCT2020 C4591001 1016 10161319/ Placebo 12 Female 159.51 111.18 43.6 White Hispanic/Latino 16OCT2020 C4591001 1016 10161320/ BNT162b2 (30 μg) 14 Male 168.91 68.18 23.8 White Non-Hispanic/non- Latino 19OCT2020 C4591001 1016 10161322/ BNT162b2 (30 μg) 14 Female 160.02 65.45 25.5 White Hispanic/Latino 19OCT2020 C4591001 1016 10161323/ BNT162b2 (30 μg) 13 Female 165.1 67.82 24.8 Black or African American Non-Hispanic/non- Latino 19OCT2020 C4591001 1016 10161324/ Placebo 15 Female 165.1 64.55 23.6 Black or African American Non-Hispanic/non- Latino 19OCT2020 C4591001 1016 10161325/ BNT162b2 (30 μg) 14 Female 170.18 79.55 27.4 White Non-Hispanic/non- Latino 19OCT2020 C4591001 1016 10161326/ BNT162b2 (30 μg) 14 Male 175.26 68.45 22.2 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1016 10161327/ Placebo 12 Male 170.18 52.73 18.2 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1016 10161329/ Placebo 14 Male 176.53 108.18 34.6 White Non-Hispanic/non- Latino 20OCT2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 70 FDA-CBER-2022-5812-0224374 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1016 10161330/ BNT162b2 (30 μg) 13 Female 155.45 45.95 19 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1016 10161331/ Placebo 12 Female 161.29 65.27 25 White Non-Hispanic/non- Latino 20OCT2020 C4591001 1016 10161332/ BNT162b2 (30 μg) 14 Male 162.56 68.64 25.9 Black or African American Non-Hispanic/non- Latino 21OCT2020 C4591001 1016 10161334/ Placebo 14 Female 177.8 78.73 24.8 White Non-Hispanic/non- Latino 21OCT2020 C4591001 1016 10161335/ BNT162b2 (30 μg) 13 Female 170.18 101.73 35 White Non-Hispanic/non- Latino 21OCT2020 C4591001 1016 10161336/ Placebo 15 Female 161.29 56 21.5 White Non-Hispanic/non- Latino 21OCT2020 C4591001 1016 10161337/ Placebo 15 Female 162.56 53.91 20.4 White Non-Hispanic/non- Latino 21OCT2020 C4591001 1016 10161338/ BNT162b2 (30 μg) 12 Male 162.56 45 17 Black or African American Non-Hispanic/non- Latino 22OCT2020 C4591001 1016 10161339/ BNT162b2 (30 μg) 13 Male 160.02 49.09 19.1 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1016 10161340/ Placebo 12 Male 163.83 84.64 31.5 White Non-Hispanic/non- Latino 22OCT2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 71 FDA-CBER-2022-5812-0224375 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1016 10161343/ BNT162b2 (30 μg) 14 Male 173.99 79.55 26.2 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1016 10161344/ Placebo 15 Female 152.4 51.36 22.1 White Non-Hispanic/non- Latino 22OCT2020 C4591001 1016 10161350/ BNT162b2 (30 μg) 14 Male 170.18 53.18 18.3 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1016 10161351/ Placebo 14 Female 162.05 55.82 21.2 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1016 10161352/ Placebo 15 Female 155.7 44.82 18.4 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1016 10161353/ Placebo 13 Female 147.32 33.45 15.4 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1016 10161354/ BNT162b2 (30 μg) 14 Female 171.45 56.36 19.1 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1016 10161356/ BNT162b2 (30 μg) 13 Male 163.83 55.82 20.8 White Hispanic/Latino 02DEC2020 C4591001 1016 10161357/ BNT162b2 (30 μg) 12 Male 172.72 62.27 20.8 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1016 10161358/ Placebo 13 Male 172.72 56.27 18.8 White Non-Hispanic/non- Latino 03DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 72 FDA-CBER-2022-5812-0224376 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1016 10161361/ Placebo 13 Male 167.64 48.91 17.4 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1016 10161362/ BNT162b2 (30 μg) 12 Male 148.59 30.91 14 Black or African American Non-Hispanic/non- Latino 04DEC2020 C4591001 1016 10161363/ BNT162b2 (30 μg) 15 Female 162.56 59.64 22.5 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1016 10161364/ BNT162b2 (30 μg) 15 Female 158.75 46.36 18.4 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1016 10161365/ Placebo 13 Female 163.83 76.55 28.5 Multiracial Non-Hispanic/non- Latino 10DEC2020 C4591001 1016 10161366/ Placebo 12 Male 162.56 65.82 24.9 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1016 10161367/ Placebo 12 Female 165.1 87.36 32 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1016 10161368/ Placebo 12 Female 148.08 35 15.9 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1016 10161369/ BNT162b2 (30 μg) 12 Female 140.97 37.55 18.9 White Hispanic/Latino 30DEC2020 C4591001 1016 10161370/ BNT162b2 (30 μg) 15 Male 173.99 63.18 20.8 Multiracial Non-Hispanic/non- Latino 04JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 73 FDA-CBER-2022-5812-0224377 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1016 10161371/ Placebo 12 Female 167.64 55.45 19.7 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1016 10161372/ Placebo 14 Female 162.56 75.64 28.6 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1016 10161373/ BNT162b2 (30 μg) 14 Female 160.02 75.09 29.3 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1016 10161374/ BNT162b2 (30 μg) 13 Female 160.02 49.45 19.3 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1016 10161375/ Placebo 14 Female 165.1 46.73 17.1 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1016 10161376/ BNT162b2 (30 μg) 15 Female 168.91 70.36 24.6 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1016 10161377/ BNT162b2 (30 μg) 13 Female 163.83 55.36 20.6 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1016 10161378/ Placebo 12 Male 153.16 37.27 15.9 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1016 10161379/ Placebo 13 Male 176.53 77.73 24.9 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1016 10161381/ BNT162b2 (30 μg) 15 Male 184.91 70.09 20.5 White Non-Hispanic/non- Latino 08JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 74 FDA-CBER-2022-5812-0224378 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1016 10161382/ BNT162b2 (30 μg) 12 Male 172.72 62.18 20.8 Asian Other Non-Hispanic/non- Latino 08JAN2021 C4591001 1016 10161383/ Placebo 12 Male 175.26 71 23.1 Asian Other Non-Hispanic/non- Latino 08JAN2021 C4591001 1016 10161384/ BNT162b2 (30 μg) 13 Female 172.72 57 19.1 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1016 10161385/ Placebo 14 Male 177.29 53.64 17 Black or African American Non-Hispanic/non- Latino 08JAN2021 C4591001 1016 10161386/ Placebo 13 Female 152.4 36.82 15.8 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1016 10161387/ BNT162b2 (30 μg) 14 Female 170.18 89.55 30.9 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1016 10161388/ Placebo 15 Female 166.37 80.82 29.1 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1039 10391246/ Placebo 15 Male 183.5 71.8 21.3 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1039 10391247/ BNT162b2 (30 μg) 12 Male 149 33.6 15.1 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1039 10391250/ BNT162b2 (30 μg) 14 Female 167.5 60.6 21.6 White Non-Hispanic/non- Latino 04DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 75 FDA-CBER-2022-5812-0224379 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391251/ Placebo 15 Female 165.6 53.5 19.5 Asian Non-Hispanic/non- Latino 07DEC2020 C4591001 1039 10391252/ Placebo 15 Male 180.1 87.2 26.9 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1039 10391253/ BNT162b2 (30 μg) 12 Female 159.5 68.6 27 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1039 10391255/ BNT162b2 (30 μg) 12 Male 174.1 73.6 24.3 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1039 10391256/ Placebo 12 Male 167.5 51.6 18.4 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1039 10391258/ Placebo 13 Female 167.5 75.8 27 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1039 10391259/ Placebo 13 Male 168 77.5 27.5 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1039 10391260/ BNT162b2 (30 μg) 14 Male 169.5 64.1 22.3 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1039 10391262/ BNT162b2 (30 μg) 14 Female 158 51.3 20.5 White Hispanic/Latino 08DEC2020 C4591001 1039 10391263/ BNT162b2 (30 μg) 13 Male 177.4 69.8 22.2 White Non-Hispanic/non- Latino 08DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 76 FDA-CBER-2022-5812-0224380 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391264/ Placebo 12 Female 158.5 43.8 17.4 Asian Hispanic/Latino 08DEC2020 C4591001 1039 10391265/ BNT162b2 (30 μg) 12 Male 152.7 40.4 17.3 Asian Hispanic/Latino 08DEC2020 C4591001 1039 10391266/ Placebo 12 Male 158 39.1 15.7 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1039 10391267/ BNT162b2 (30 μg) 15 Female 164.3 53.1 19.7 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1039 10391268/ Placebo 13 Female 160 47.1 18.4 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1039 10391269/ BNT162b2 (30 μg) 12 Male 162.1 45 17.1 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1039 10391270/ Placebo 13 Female 166.6 58.1 20.9 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1039 10391271/ Placebo 14 Female 169 63.6 22.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1039 10391272/ BNT162b2 (30 μg) 12 Male 165.5 43.7 16 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1039 10391273/ Placebo 12 Female 165.5 45.2 16.5 White Non-Hispanic/non- Latino 09DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 77 FDA-CBER-2022-5812-0224381 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391274/ Placebo 13 Male 165.5 48.5 17.7 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1039 10391275/ BNT162b2 (30 μg) 12 Male 160 40.4 15.8 White Hispanic/Latino 16DEC2020 C4591001 1039 10391276/ BNT162b2 (30 μg) 13 Male 174 82 27.1 Asian Other Non-Hispanic/non- Latino 16DEC2020 C4591001 1039 10391277/ Placebo 14 Female 165.3 45.8 16.8 Black or African American Non-Hispanic/non- Latino 16DEC2020 C4591001 1039 10391278/ BNT162b2 (30 μg) 12 Male 152.3 39.4 17 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1039 10391279/ Placebo 14 Female 151 43.2 18.9 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1039 10391280/ Placebo 13 Female 156.9 68.9 28 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1039 10391281/ BNT162b2 (30 μg) 15 Female 171.5 87.6 29.8 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1039 10391282/ BNT162b2 (30 μg) 13 Male 165 48.1 17.7 White Hispanic/Latino 18DEC2020 C4591001 1039 10391283/ Placebo 15 Male 170.5 51.9 17.9 White Non-Hispanic/non- Latino 18DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 78 FDA-CBER-2022-5812-0224382 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391284/ BNT162b2 (30 μg) 13 Male 169 59.7 20.9 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1039 10391285/ Placebo 13 Female 156.1 40.8 16.7 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1039 10391286/ BNT162b2 (30 μg) 13 Female 152.2 40.6 17.5 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1039 10391287/ Placebo 14 Female 161.5 54.2 20.8 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1039 10391289/ BNT162b2 (30 μg) 15 Male 177.5 64.3 20.4 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1039 10391290/ BNT162b2 (30 μg) 12 Female 155.5 41.8 17.3 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1039 10391291/ Placebo 15 Female 167.5 63.8 22.7 White Hispanic/Latino 18DEC2020 C4591001 1039 10391292/ Placebo 13 Female 169 64.1 22.4 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1039 10391293/ BNT162b2 (30 μg) 14 Male 168 63.3 22.4 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1039 10391294/ Placebo 13 Male 167.5 46.6 16.6 Asian Other Non-Hispanic/non- Latino 21DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 79 FDA-CBER-2022-5812-0224383 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391295/ BNT162b2 (30 μg) 13 Female 159.5 78.1 30.7 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1039 10391296/ Placebo 13 Male 158.4 47.2 18.8 White Not reported 29DEC2020 C4591001 1039 10391297/ BNT162b2 (30 μg) 13 Male 168.6 49.1 17.3 White Hispanic/Latino 29DEC2020 C4591001 1039 10391298/ BNT162b2 (30 μg) 14 Male 186.2 75.2 21.7 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1039 10391299/ Placebo 15 Male 176.4 63.3 20.3 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1039 10391300/ BNT162b2 (30 μg) 12 Male 153.4 44.2 18.8 White Hispanic/Latino 29DEC2020 C4591001 1039 10391301/ Placebo 14 Male 154.5 45 18.9 White Hispanic/Latino 29DEC2020 C4591001 1039 10391302/ BNT162b2 (30 μg) 14 Male 170.6 47.3 16.3 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1039 10391303/ Placebo 13 Male 162 64.4 24.5 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1039 10391304/ BNT162b2 (30 μg) 13 Male 167 41.1 14.7 White Non-Hispanic/non- Latino 29DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 80 FDA-CBER-2022-5812-0224384 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391305/ Placebo 13 Male 169.5 55.7 19.4 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1039 10391306/ BNT162b2 (30 μg) 12 Male 155.5 51.6 21.3 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1039 10391307/ Placebo 15 Female 169.7 61.2 21.3 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1039 10391308/ BNT162b2 (30 μg) 13 Female 155.1 42 17.5 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1039 10391309/ Placebo 14 Male 172.2 52.7 17.8 Asian Other Non-Hispanic/non- Latino 07JAN2021 C4591001 1039 10391310/ Placebo 13 Male 158 73.1 29.3 White Hispanic/Latino 07JAN2021 C4591001 1039 10391311/ BNT162b2 (30 μg) 15 Male 167 65.7 23.6 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1039 10391312/ BNT162b2 (30 μg) 13 Male 171 59.3 20.3 White Hispanic/Latino 07JAN2021 C4591001 1039 10391313/ Placebo 14 Male 175 53.1 17.3 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1039 10391314/ Placebo 14 Female 167.4 65.9 23.5 Asian Other Non-Hispanic/non- Latino 07JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 81 FDA-CBER-2022-5812-0224385 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391315/ BNT162b2 (30 μg) 14 Male 172.5 49.3 16.6 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1039 10391316/ BNT162b2 (30 μg) 12 Female 156 48.5 19.9 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1039 10391317/ Placebo 12 Male 168.6 66.2 23.3 Asian Other Non-Hispanic/non- Latino 07JAN2021 C4591001 1039 10391318/ BNT162b2 (30 μg) 15 Female 163 66.8 25.1 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1039 10391319/ Placebo 12 Male 156.1 55.5 22.8 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1039 10391320/ Placebo 12 Female 167.1 49.1 17.6 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1039 10391321/ Placebo 12 Female 166 43.5 15.8 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1039 10391322/ BNT162b2 (30 μg) 15 Female 164 47.7 17.7 White Hispanic/Latino 08JAN2021 C4591001 1039 10391323/ BNT162b2 (30 μg) 13 Female 164 63 23.4 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1039 10391324/ BNT162b2 (30 μg) 12 Female 155.4 58.1 24.1 White Non-Hispanic/non- Latino 08JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 82 FDA-CBER-2022-5812-0224386 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391325/ Placebo 13 Female 155.8 42.1 17.3 Asian Other Non-Hispanic/non- Latino 11JAN2021 C4591001 1039 10391326/ BNT162b2 (30 μg) 15 Male 177.7 65.5 20.7 Asian Other Non-Hispanic/non- Latino 11JAN2021 C4591001 1039 10391327/ Placebo 15 Male 169 59.4 20.8 White Hispanic/Latino 11JAN2021 C4591001 1039 10391328/ Placebo 14 Female 164 67.5 25.1 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1039 10391329/ Placebo 13 Male 168.1 76.2 27 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1039 10391330/ BNT162b2 (30 μg) 15 Male 182 67 20.2 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1039 10391331/ BNT162b2 (30 μg) 13 Male 160 42.5 16.6 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1039 10391332/ BNT162b2 (30 μg) 13 Female 156 38.7 15.9 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1039 10391333/ Placebo 15 Male 171.6 72 24.5 White Hispanic/Latino 12JAN2021 C4591001 1039 10391334/ Placebo 12 Male 149.1 38.9 17.5 White Hispanic/Latino 12JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 83 FDA-CBER-2022-5812-0224387 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1039 10391335/ BNT162b2 (30 μg) 15 Male 175 54.3 17.7 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1039 10391336/ BNT162b2 (30 μg) 14 Male 177.4 62.2 19.8 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1039 10391337/ Placebo 15 Male 182.4 84.7 25.5 White Hispanic/Latino 12JAN2021 C4591001 1039 10391338/ BNT162b2 (30 μg) 15 Female 150 48.9 21.7 White Hispanic/Latino 12JAN2021 C4591001 1039 10391339/ Placebo 12 Female 149.5 40.7 18.2 White Hispanic/Latino 12JAN2021 C4591001 1044 10441251/ BNT162b2 (30 μg) 14 Female 160 59.1 23.1 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1044 10441252/ Placebo 13 Male 167.6 45.9 16.3 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1044 10441253/ BNT162b2 (30 μg) 13 Male 163.8 46.8 17.4 White Hispanic/Latino 30NOV2020 C4591001 1044 10441255/ BNT162b2 (30 μg) 12 Male 156.2 67.2 27.5 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1044 10441256/ Placebo 14 Male 167.6 60.1 21.4 White Non-Hispanic/non- Latino 01DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 84 FDA-CBER-2022-5812-0224388 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441257/ BNT162b2 (30 μg) 14 Female 159.4 55 21.6 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1044 10441259/ BNT162b2 (30 μg) 12 Female 150.5 43.4 19.2 Asian Non-Hispanic/non- Latino 01DEC2020 C4591001 1044 10441260/ Placebo 15 Male 172.7 72.9 24.4 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1044 10441261/ Placebo 14 Female 160 67.2 26.2 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1044 10441263/ BNT162b2 (30 μg) 13 Male 165.1 53 19.4 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1044 10441264/ Placebo 14 Female 167.6 98.3 35 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1044 10441265/ Placebo 14 Male 157.5 37 14.9 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1044 10441266/ BNT162b2 (30 μg) 14 Female 165.1 74.2 27.2 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1044 10441267/ Placebo 14 Male 170.2 58.6 20.2 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1044 10441268/ BNT162b2 (30 μg) 15 Male 180.3 129.2 39.7 White Non-Hispanic/non- Latino 08DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 85 FDA-CBER-2022-5812-0224389 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441270/ BNT162b2 (30 μg) 13 Female 148.6 38.6 17.5 Not reported Hispanic/Latino 08DEC2020 C4591001 1044 10441271/ Placebo 15 Female 183.5 51.7 15.4 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1044 10441273/ BNT162b2 (30 μg) 12 Female 149.9 46.5 20.7 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1044 10441274/ Placebo 15 Male 170.2 66.3 22.9 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1044 10441275/ Placebo 12 Female 168.9 53.4 18.7 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1044 10441276/ BNT162b2 (30 μg) 14 Male 177.8 56.2 17.8 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1044 10441277/ Placebo 15 Female 172.7 49.7 16.7 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1044 10441278/ BNT162b2 (30 μg) 13 Female 168.9 87.1 30.5 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1044 10441279/ BNT162b2 (30 μg) 15 Female 160 55.5 21.7 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1044 10441280/ Placebo 15 Male 175.3 70.5 22.9 White Non-Hispanic/non- Latino 09DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 86 FDA-CBER-2022-5812-0224390 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441281/ BNT162b2 (30 μg) 15 Male 171.5 54.4 18.5 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1044 10441282/ Placebo 15 Male 180.3 66.5 20.5 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1044 10441283/ BNT162b2 (30 μg) 14 Male 171.5 48.1 16.4 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1044 10441284/ Placebo 15 Male 179.1 68.7 21.4 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1044 10441285/ BNT162b2 (30 μg) 15 Female 157.5 58 23.4 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1044 10441286/ Placebo 15 Female 163.8 62.1 23.1 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1044 10441288/ BNT162b2 (30 μg) 12 Female 165.7 29 10.6 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1044 10441289/ Placebo 13 Female 157.5 37.8 15.2 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1044 10441290/ BNT162b2 (30 μg) 12 Female 152.4 42.5 18.3 Asian Other Non-Hispanic/non- Latino 16DEC2020 C4591001 1044 10441291/ BNT162b2 (30 μg) 13 Male 160 46.6 18.2 White Non-Hispanic/non- Latino 17DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 87 FDA-CBER-2022-5812-0224391 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441292/ Placebo 15 Male 172.7 51.9 17.4 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1044 10441293/ Placebo 12 Male 162.6 58.8 22.2 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1044 10441294/ Placebo 14 Male 181.6 63.3 19.2 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1044 10441295/ BNT162b2 (30 μg) 12 Male 154.9 45.7 19 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1044 10441296/ BNT162b2 (30 μg) 13 Male 161.3 56.8 21.8 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1044 10441297/ BNT162b2 (30 μg) 14 Female 168.9 50.7 17.8 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1044 10441298/ Placebo 14 Female 161.3 39.6 15.2 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1044 10441299/ Placebo 15 Male 188 74.8 21.2 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1044 10441300/ BNT162b2 (30 μg) 15 Male 180.3 95.5 29.4 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1044 10441301/ BNT162b2 (30 μg) 15 Female 165.1 49.9 18.3 White Non-Hispanic/non- Latino 29DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 88 FDA-CBER-2022-5812-0224392 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441302/ Placebo 14 Female 170.8 58.2 20 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1044 10441303/ Placebo 15 Male 188 60.3 17.1 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1044 10441304/ BNT162b2 (30 μg) 15 Female 167.6 57.5 20.5 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1044 10441306/ BNT162b2 (30 μg) 12 Male 158.1 57.3 22.9 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1044 10441307/ Placebo 14 Male 168.9 62 21.7 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1044 10441308/ Placebo 12 Male 165.1 44.9 16.5 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1044 10441309/ BNT162b2 (30 μg) 12 Male 167.6 74.2 26.4 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1044 10441310/ BNT162b2 (30 μg) 13 Male 162.6 51.9 19.6 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1044 10441311/ BNT162b2 (30 μg) 12 Female 157.5 46.7 18.8 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1044 10441312/ Placebo 14 Male 167.6 48.4 17.2 White Non-Hispanic/non- Latino 04JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 89 FDA-CBER-2022-5812-0224393 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441313/ Placebo 14 Female 166.4 48.5 17.5 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1044 10441314/ BNT162b2 (30 μg) 14 Female 165.1 56.3 20.7 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1044 10441315/ Placebo 14 Female 172.7 56 18.8 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1044 10441316/ BNT162b2 (30 μg) 15 Male 177.8 67.4 21.3 White Hispanic/Latino 04JAN2021 C4591001 1044 10441317/ Placebo 13 Female 167.6 51.5 18.3 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1044 10441318/ Placebo 14 Female 172.7 52.3 17.5 Black or African American Non-Hispanic/non- Latino 05JAN2021 C4591001 1044 10441319/ BNT162b2 (30 μg) 12 Male 172.7 53.3 17.9 Black or African American Non-Hispanic/non- Latino 05JAN2021 C4591001 1044 10441320/ Placebo 15 Male 177.8 65.8 20.8 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1044 10441321/ BNT162b2 (30 μg) 14 Male 160 78.3 30.6 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1044 10441322/ BNT162b2 (30 μg) 14 Male 160 83.6 32.7 Asian Other Non-Hispanic/non- Latino 05JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 90 FDA-CBER-2022-5812-0224394 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441323/ Placebo 15 Male 182.9 65.2 19.5 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1044 10441324/ Placebo 15 Female 168.9 59.6 20.9 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1044 10441325/ BNT162b2 (30 μg) 12 Male 165.1 55.4 20.3 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1044 10441326/ Placebo 13 Female 157.5 40.8 16.4 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1044 10441327/ Placebo 15 Female 170.2 62.1 21.4 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1044 10441328/ BNT162b2 (30 μg) 15 Female 160 60.1 23.5 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1044 10441329/ BNT162b2 (30 μg) 12 Female 163.8 55.1 20.5 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1044 10441330/ Placebo 14 Female 159.8 44.9 17.6 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1044 10441331/ BNT162b2 (30 μg) 12 Male 162.6 43.1 16.3 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1044 10441332/ Placebo 15 Male 173.4 58.6 19.5 White Non-Hispanic/non- Latino 06JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 91 FDA-CBER-2022-5812-0224395 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441333/ BNT162b2 (30 μg) 13 Male 160 38.1 14.9 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1044 10441334/ BNT162b2 (30 μg) 12 Female 157.5 45 18.1 White Hispanic/Latino 07JAN2021 C4591001 1044 10441335/ Placebo 15 Female 161.9 60.1 22.9 White Hispanic/Latino 07JAN2021 C4591001 1044 10441336/ BNT162b2 (30 μg) 12 Female 157.5 41.3 16.6 Asian Other Non-Hispanic/non- Latino 07JAN2021 C4591001 1044 10441337/ Placebo 13 Male 152.4 36.8 15.8 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1044 10441338/ Placebo 13 Female 170.2 44.7 15.4 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1044 10441339/ BNT162b2 (30 μg) 15 Female 171.5 55.1 18.7 Asian Other Non-Hispanic/non- Latino 08JAN2021 C4591001 1044 10441340/ Placebo 13 Male 157.5 57.9 23.3 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1044 10441341/ Placebo 14 Male 165.1 49.4 18.1 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1044 10441342/ BNT162b2 (30 μg) 13 Male 170.2 42.5 14.7 White Non-Hispanic/non- Latino 09JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 92 FDA-CBER-2022-5812-0224396 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441343/ BNT162b2 (30 μg) 14 Male 162.6 39.9 15.1 Asian Other Non-Hispanic/non- Latino 09JAN2021 C4591001 1044 10441344/ Placebo 15 Male 165.1 69.8 25.6 Asian Other Non-Hispanic/non- Latino 09JAN2021 C4591001 1044 10441345/ Placebo 12 Female 157.5 38.3 15.4 White Non-Hispanic/non- Latino 09JAN2021 C4591001 1044 10441346/ BNT162b2 (30 μg) 12 Male 160 53.5 20.9 White Non-Hispanic/non- Latino 09JAN2021 C4591001 1044 10441347/ Placebo 14 Female 157.5 59.1 23.8 White Non-Hispanic/non- Latino 09JAN2021 C4591001 1044 10441348/ Placebo 13 Male 157.5 36.1 14.6 White Non-Hispanic/non- Latino 09JAN2021 C4591001 1044 10441349/ BNT162b2 (30 μg) 13 Male 170.2 72.2 24.9 White Non-Hispanic/non- Latino 09JAN2021 C4591001 1044 10441350/ BNT162b2 (30 μg) 15 Female 157.5 54.7 22.1 Asian Other Non-Hispanic/non- Latino 09JAN2021 C4591001 1044 10441351/ Placebo 15 Male 180.3 81.3 25 White Non-Hispanic/non- Latino 10JAN2021 C4591001 1044 10441352/ BNT162b2 (30 μg) 15 Female 162.6 54 20.4 White Hispanic/Latino 10JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 93 FDA-CBER-2022-5812-0224397 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441353/ BNT162b2 (30 μg) 13 Female 165.1 58.9 21.6 White Non-Hispanic/non- Latino 10JAN2021 C4591001 1044 10441354/ Placebo 13 Female 160 42.9 16.8 White Non-Hispanic/non- Latino 10JAN2021 C4591001 1044 10441355/ BNT162b2 (30 μg) 14 Female 163.8 55.4 20.6 Asian Other Non-Hispanic/non- Latino 10JAN2021 C4591001 1044 10441356/ Placebo 12 Male 163.8 42.4 15.8 White Non-Hispanic/non- Latino 10JAN2021 C4591001 1044 10441357/ Placebo 13 Male 148.6 39.2 17.8 White Hispanic/Latino 10JAN2021 C4591001 1044 10441358/ BNT162b2 (30 μg) 14 Male 174 45.4 15 Asian Other Non-Hispanic/non- Latino 10JAN2021 C4591001 1044 10441359/ BNT162b2 (30 μg) 15 Female 166.4 61.1 22.1 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441360/ Placebo 13 Male 177.8 55.9 17.7 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441361/ BNT162b2 (30 μg) 15 Male 183.5 60.2 17.9 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441362/ Placebo 14 Male 182.9 54.2 16.2 White Non-Hispanic/non- Latino 11JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 94 FDA-CBER-2022-5812-0224398 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441363/ Placebo 13 Female 174 59.2 19.6 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441364/ BNT162b2 (30 μg) 15 Female 156.2 61.5 25.2 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441365/ Placebo 15 Female 163.2 54.8 20.6 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441366/ BNT162b2 (30 μg) 15 Male 176.5 57.8 18.6 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441367/ BNT162b2 (30 μg) 12 Male 154.9 92 38.3 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441368/ Placebo 15 Female 162.6 56.2 21.3 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441369/ BNT162b2 (30 μg) 12 Male 154.9 80.6 33.6 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441370/ Placebo 15 Male 175.3 54.2 17.6 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441371/ Placebo 15 Female 160 55 21.5 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1044 10441372/ BNT162b2 (30 μg) 13 Male 167.6 65.1 23.2 White Non-Hispanic/non- Latino 11JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 95 FDA-CBER-2022-5812-0224399 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441373/ Placebo 14 Female 156.2 43.9 18 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441374/ Placebo 15 Male 174 53.4 17.6 White Hispanic/Latino 12JAN2021 C4591001 1044 10441375/ BNT162b2 (30 μg) 13 Female 154.9 44.2 18.4 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441376/ BNT162b2 (30 μg) 15 Male 162.6 47.4 17.9 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441377/ BNT162b2 (30 μg) 12 Female 165.1 49.9 18.3 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441378/ BNT162b2 (30 μg) 12 Female 152.4 40.5 17.4 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441379/ BNT162b2 (30 μg) 15 Male 168.9 54.5 19.1 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441380/ Placebo 13 Male 165.1 44.2 16.2 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441381/ Placebo 12 Male 167.6 42.9 15.3 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441382/ Placebo 13 Female 160 51.6 20.2 White Non-Hispanic/non- Latino 12JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 96 FDA-CBER-2022-5812-0224400 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1044 10441383/ BNT162b2 (30 μg) 14 Male 175.3 61.3 19.9 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1044 10441384/ Placebo 13 Male 174 96.8 32 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1057 10571376/ BNT162b2 (30 μg) 13 Male 167.2 55.2 19.7 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1057 10571377/ Placebo 13 Female 159.2 49.8 19.6 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1057 10571378/ BNT162b2 (30 μg) 12 Female 161.3 85.8 33 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1057 10571379/ Placebo 14 Female 163.5 63.5 23.8 Asian Other Non-Hispanic/non- Latino 07DEC2020 C4591001 1057 10571380/ BNT162b2 (30 μg) 13 Female 157.1 43 17.4 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1057 10571382/ BNT162b2 (30 μg) 13 Female 151.7 52.6 22.9 Black or African American Non-Hispanic/non- Latino 08DEC2020 C4591001 1057 10571383/ Placebo 14 Female 160.5 59.5 23.1 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1057 10571384/ Placebo 15 Male 155.2 44 18.3 White Non-Hispanic/non- Latino 08DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 97 FDA-CBER-2022-5812-0224401 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1057 10571385/ BNT162b2 (30 μg) 15 Female 174.5 61.5 20.2 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1057 10571386/ Placebo 14 Male 171.5 115.8 39.4 Black or African American Non-Hispanic/non- Latino 08DEC2020 C4591001 1057 10571387/ Placebo 14 Female 158.2 59.9 23.9 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1057 10571388/ BNT162b2 (30 μg) 14 Male 166 45 16.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1057 10571389/ Placebo 12 Female 165.5 48.5 17.7 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1057 10571390/ BNT162b2 (30 μg) 15 Male 173 79.5 26.6 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1057 10571391/ Placebo 15 Male 178.3 66 20.8 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1057 10571392/ BNT162b2 (30 μg) 15 Female 165.8 55.9 20.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1057 10571393/ Placebo 15 Female 161.5 42 16.1 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1057 10571394/ Placebo 15 Female 155.6 64.5 26.6 White Non-Hispanic/non- Latino 09DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 98 FDA-CBER-2022-5812-0224402 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1057 10571395/ BNT162b2 (30 μg) 13 Female 163 71.2 26.8 Black or African American Non-Hispanic/non- Latino 09DEC2020 C4591001 1057 10571396/ BNT162b2 (30 μg) 13 Male 161 44 17 Black or African American Non-Hispanic/non- Latino 10DEC2020 C4591001 1057 10571397/ BNT162b2 (30 μg) 14 Female 161.5 63.2 24.2 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1057 10571398/ Placebo 14 Male 180 64 19.8 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1057 10571399/ BNT162b2 (30 μg) 12 Male 160 66.5 26 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1057 10571400/ Placebo 13 Male 168 59.5 21.1 Black or African American Non-Hispanic/non- Latino 11DEC2020 C4591001 1057 10571401/ BNT162b2 (30 μg) 13 Female 172.7 70.9 23.8 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1057 10571402/ Placebo 15 Female 169 86 30.1 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1057 10571403/ BNT162b2 (30 μg) 12 Male 154.5 41.3 17.3 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1057 10571404/ Placebo 13 Female 155.3 64 26.5 White Non-Hispanic/non- Latino 16DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 99 FDA-CBER-2022-5812-0224403 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1057 10571405/ BNT162b2 (30 μg) 15 Male 175.8 63.1 20.4 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1057 10571406/ Placebo 13 Male 166.8 55.2 19.8 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1057 10571407/ Placebo 15 Male 171.9 53.3 18 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1057 10571408/ Placebo 14 Male 176.7 58.2 18.6 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1057 10571409/ BNT162b2 (30 μg) 12 Male 146.8 33.3 15.5 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1057 10571410/ Placebo 12 Male 147.8 34.2 15.7 Asian Other Non-Hispanic/non- Latino 17DEC2020 C4591001 1057 10571411/ BNT162b2 (30 μg) 15 Female 155.8 47 19.4 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1057 10571412/ BNT162b2 (30 μg) 13 Male 165.4 54.8 20 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1057 10571413/ BNT162b2 (30 μg) 13 Male 160.3 49.4 19.2 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1057 10571414/ Placebo 15 Female 163.2 47.9 18 Multiracial Hispanic/Latino 21DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 100 FDA-CBER-2022-5812-0224404 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1057 10571415/ Placebo 14 Female 163 42.5 16 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1057 10571416/ BNT162b2 (30 μg) 14 Male 161 55.3 21.3 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1057 10571417/ Placebo 14 Female 158 70.1 28.1 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1057 10571418/ BNT162b2 (30 μg) 14 Female 161.5 114.8 44 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1057 10571419/ BNT162b2 (30 μg) 14 Male 173.8 67 22.2 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1057 10571420/ Placebo 14 Male 171.2 56.5 19.3 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1057 10571421/ Placebo 15 Male 166.7 111.5 40.1 Black or African American Non-Hispanic/non- Latino 23DEC2020 C4591001 1057 10571422/ BNT162b2 (30 μg) 14 Male 175 119 38.9 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1057 10571423/ BNT162b2 (30 μg) 15 Male 175.2 78.3 25.5 Black or African American Hispanic/Latino 24DEC2020 C4591001 1057 10571424/ Placebo 12 Male 172.6 80 26.9 Black or African American Hispanic/Latino 24DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 101 FDA-CBER-2022-5812-0224405 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1057 10571425/ Placebo 13 Female 157.8 41 16.5 White Non-Hispanic/non- Latino 24DEC2020 C4591001 1057 10571426/ BNT162b2 (30 μg) 12 Female 148 36.6 16.7 White Hispanic/Latino 24DEC2020 C4591001 1057 10571427/ BNT162b2 (30 μg) 12 Female 148.5 31.6 14.3 White Hispanic/Latino 24DEC2020 C4591001 1057 10571428/ Placebo 14 Male 154.5 37.8 15.8 White Hispanic/Latino 24DEC2020 C4591001 1057 10571429/ BNT162b2 (30 μg) 15 Female 162.9 56.2 21.2 White Hispanic/Latino 24DEC2020 C4591001 1057 10571430/ BNT162b2 (30 μg) 12 Female 172.6 104.3 35 Black or African American Non-Hispanic/non- Latino 29DEC2020 C4591001 1057 10571431/ Placebo 13 Male 161 49.3 19 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1057 10571432/ Placebo 12 Female 155.1 33.1 13.8 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1057 10571433/ BNT162b2 (30 μg) 12 Female 166 67.5 24.5 Black or African American Non-Hispanic/non- Latino 30DEC2020 C4591001 1057 10571434/ Placebo 13 Male 159 92.5 36.6 Multiracial Non-Hispanic/non- Latino 31DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 102 FDA-CBER-2022-5812-0224406 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1057 10571435/ BNT162b2 (30 μg) 12 Male 156.2 69.3 28.4 Black or African American Hispanic/Latino 04JAN2021 C4591001 1057 10571436/ Placebo 14 Female 165 60 22 Black or African American Hispanic/Latino 04JAN2021 C4591001 1057 10571437/ Placebo 15 Male 173.5 64.5 21.4 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1057 10571438/ BNT162b2 (30 μg) 13 Female 172.3 71.6 24.1 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1057 10571439/ Placebo 14 Female 163.4 48.1 18 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1057 10571440/ BNT162b2 (30 μg) 12 Male 166.5 47.7 17.2 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1057 10571441/ Placebo 13 Male 162.2 51.7 19.7 Asian Other Non-Hispanic/non- Latino 06JAN2021 C4591001 1057 10571442/ Placebo 13 Male 168 62.3 22.1 Black or African American Non-Hispanic/non- Latino 07JAN2021 C4591001 1057 10571443/ BNT162b2 (30 μg) 12 Female 169.6 68 23.6 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1057 10571444/ BNT162b2 (30 μg) 14 Female 168.6 58.2 20.5 White Non-Hispanic/non- Latino 08JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 103 FDA-CBER-2022-5812-0224407 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1057 10571445/ BNT162b2 (30 μg) 15 Male 183.5 88.2 26.2 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1057 10571446/ Placebo 13 Female 168.4 55.1 19.4 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1057 10571447/ Placebo 15 Male 189.5 115.3 32.1 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1057 10571448/ BNT162b2 (30 μg) 13 Female 167 67 24 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1057 10571449/ Placebo 12 Male 169.5 37 12.9 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1057 10571450/ Placebo 13 Male 176 62.7 20.2 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1057 10571451/ BNT162b2 (30 μg) 12 Female 177.4 55.1 17.5 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1057 10571452/ BNT162b2 (30 μg) 12 Female 168.5 63.5 22.4 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1057 10571453/ Placebo 13 Male 169.5 57.6 20 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1057 10571454/ BNT162b2 (30 μg) 13 Female 160 46.4 18.1 White Non-Hispanic/non- Latino 12JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 104 FDA-CBER-2022-5812-0224408 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1066 10661394/ Placebo 14 Male 168.91 58.27 20.4 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1066 10661395/ BNT162b2 (30 μg) 12 Male 161.29 101.09 38.8 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1066 10661397/ Placebo 14 Male 180.34 60.64 18.6 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1066 10661401/ Placebo 14 Male 172.72 57.86 19.4 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1066 10661402/ BNT162b2 (30 μg) 14 Female 162.56 54.36 20.5 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1066 10661403/ Placebo 14 Male 158.75 53.27 21.1 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1066 10661404/ BNT162b2 (30 μg) 12 Female 160.02 58.5 22.8 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1066 10661405/ Placebo 13 Male 157.48 40.09 16.1 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1066 10661407/ BNT162b2 (30 μg) 15 Female 177.8 62.27 19.7 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1066 10661408/ BNT162b2 (30 μg) 15 Female 175.9 65.32 21.1 White Non-Hispanic/non- Latino 08DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 105 FDA-CBER-2022-5812-0224409 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1066 10661409/ BNT162b2 (30 μg) 12 Male 148.59 33.73 15.2 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1066 10661410/ Placebo 13 Female 162.56 60.09 22.7 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1066 10661411/ BNT162b2 (30 μg) 15 Male 168.91 65.64 23 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1066 10661412/ Placebo 14 Female 154.94 56.41 23.4 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1066 10661414/ BNT162b2 (30 μg) 15 Male 160.02 76.45 29.8 White Hispanic/Latino 14DEC2020 C4591001 1066 10661415/ Placebo 14 Female 165.1 93.45 34.2 White Hispanic/Latino 14DEC2020 C4591001 1066 10661416/ Placebo 12 Male 151.13 37.09 16.2 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1066 10661417/ BNT162b2 (30 μg) 12 Male 149.86 43.18 19.2 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1066 10661418/ Placebo 14 Male 187.96 77.73 22 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1066 10661419/ BNT162b2 (30 μg) 14 Female 157.48 42.27 17 Multiracial Non-Hispanic/non- Latino 16DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 106 FDA-CBER-2022-5812-0224410 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1066 10661420/ BNT162b2 (30 μg) 15 Female 172.72 61.45 20.6 White Hispanic/Latino 17DEC2020 C4591001 1066 10661421/ Placebo 14 Male 160.02 53.27 20.8 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1066 10661422/ BNT162b2 (30 μg) 12 Male 160.02 53.05 20.7 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1066 10661423/ Placebo 14 Male 179.71 87.55 27 White Hispanic/Latino 30DEC2020 C4591001 1066 10661424/ BNT162b2 (30 μg) 14 Male 166.37 52.73 19 Native Hawaiian or other Pacific Islander Hispanic/Latino 30DEC2020 C4591001 1066 10661425/ Placebo 14 Female 163.2 53.18 19.9 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1066 10661426/ Placebo 15 Male 173.99 54 17.8 Multiracial Non-Hispanic/non- Latino 06JAN2021 C4591001 1066 10661427/ BNT162b2 (30 μg) 15 Male 180.34 64.36 19.7 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1066 10661428/ Placebo 15 Female 165.1 59.14 21.6 Black or African American Non-Hispanic/non- Latino 06JAN2021 C4591001 1066 10661429/ Placebo 12 Male 154.94 52.73 21.9 White Non-Hispanic/non- Latino 06JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 107 FDA-CBER-2022-5812-0224411 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1066 10661430/ BNT162b2 (30 μg) 13 Male 173.99 91.73 30.2 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1066 10661431/ BNT162b2 (30 μg) 15 Female 175.26 74.73 24.3 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1066 10661432/ Placebo 14 Female 161.93 58.27 22.2 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1066 10661433/ Placebo 12 Female 152.4 56.59 24.3 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1066 10661434/ BNT162b2 (30 μg) 15 Male 165.1 53.18 19.5 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1066 10661435/ BNT162b2 (30 μg) 13 Female 157.48 42.64 17.2 White Non-Hispanic/non- Latino 12JAN2021 C4591001 1077 10771274/ BNT162b2 (30 μg) 14 Female 163.83 63.64 23.7 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1077 10771275/ Placebo 13 Male 160.02 41.45 16.2 White Non-Hispanic/non- Latino 03DEC2020 C4591001 1077 10771277/ Placebo 13 Male 158.75 39.64 15.7 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1077 10771278/ BNT162b2 (30 μg) 13 Male 165.1 47.09 17.2 White Non-Hispanic/non- Latino 04DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 108 FDA-CBER-2022-5812-0224412 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1077 10771279/ BNT162b2 (30 μg) 13 Male 163.07 48.73 18.3 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1077 10771280/ Placebo 14 Female 163.83 50.36 18.7 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1077 10771281/ BNT162b2 (30 μg) 14 Male 168 70.8 25.1 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1077 10771282/ Placebo 14 Male 180.34 67.09 20.6 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1077 10771283/ Placebo 13 Male 167 62.7 22.5 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1077 10771284/ BNT162b2 (30 μg) 15 Male 187 78.7 22.5 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1077 10771285/ Placebo 14 Female 160.02 57.55 22.4 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1077 10771286/ BNT162b2 (30 μg) 14 Female 170 62.8 21.7 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1077 10771287/ BNT162b2 (30 μg) 15 Male 172.72 60.45 20.2 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1077 10771288/ BNT162b2 (30 μg) 15 Male 180.34 72.73 22.3 Black or African American Non-Hispanic/non- Latino 16DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 109 FDA-CBER-2022-5812-0224413 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1077 10771289/ Placebo 14 Female 175.26 54.09 17.6 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1077 10771290/ Placebo 14 Female 170.18 58.91 20.3 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1077 10771291/ BNT162b2 (30 μg) 15 Male 167.64 55.36 19.7 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1077 10771292/ BNT162b2 (30 μg) 14 Male 167.64 48.55 17.2 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1077 10771293/ Placebo 12 Male 152.4 44.09 18.9 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1077 10771294/ Placebo 14 Male 167 48.9 17.5 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1077 10771295/ Placebo 15 Male 172.5 70 23.5 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1077 10771296/ BNT162b2 (30 μg) 13 Male 161 42.2 16.3 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1077 10771297/ BNT162b2 (30 μg) 12 Female 148 57.7 26.3 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1077 10771298/ Placebo 14 Male 166.37 50.36 18.2 White Non-Hispanic/non- Latino 07JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 110 FDA-CBER-2022-5812-0224414 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1077 10771299/ BNT162b2 (30 μg) 13 Male 150.5 34.4 15.2 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1077 10771300/ BNT162b2 (30 μg) 15 Female 158 62.4 25 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1084 10841541/ BNT162b2 (30 μg) 14 Male 174 84.7 28 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1084 10841542/ Placebo 15 Female 149 54.3 24.5 Asian Non-Hispanic/non- Latino 11DEC2020 C4591001 1084 10841543/ Placebo 12 Male 160 45 17.6 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1084 10841544/ BNT162b2 (30 μg) 15 Male 175.3 59.4 19.3 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1084 10841545/ Placebo 12 Female 158 51.5 20.6 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1084 10841546/ BNT162b2 (30 μg) 14 Female 158 41.2 16.5 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1084 10841547/ Placebo 15 Male 171 92.3 31.6 White Hispanic/Latino 21DEC2020 C4591001 1084 10841548/ BNT162b2 (30 μg) 13 Female 159.5 53.9 21.2 White Non-Hispanic/non- Latino 21DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 111 FDA-CBER-2022-5812-0224415 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1084 10841549/ BNT162b2 (30 μg) 14 Male 171 78 26.7 White Hispanic/Latino 21DEC2020 C4591001 1084 10841550/ Placebo 15 Male 167 54.1 19.4 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1084 10841551/ BNT162b2 (30 μg) 13 Male 158 48.4 19.4 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1084 10841552/ Placebo 13 Male 164.5 48.1 17.8 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1084 10841553/ BNT162b2 (30 μg) 15 Male 166.7 60.5 21.8 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1084 10841555/ Placebo 13 Male 176.9 67.8 21.7 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1084 10841556/ BNT162b2 (30 μg) 15 Female 167.5 75.5 26.9 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1084 10841557/ Placebo 13 Female 160 88.8 34.7 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1084 10841558/ BNT162b2 (30 μg) 15 Female 164 124.1 46.1 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1084 10841559/ BNT162b2 (30 μg) 13 Male 159 98.2 38.8 White Non-Hispanic/non- Latino 28DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 112 FDA-CBER-2022-5812-0224416 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1084 10841560/ Placebo 15 Male 177.9 58.6 18.5 White Hispanic/Latino 28DEC2020 C4591001 1084 10841561/ Placebo 15 Female 168 69.9 24.8 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1084 10841562/ BNT162b2 (30 μg) 12 Male 170 65.2 22.6 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1084 10841563/ BNT162b2 (30 μg) 13 Female 152 42.5 18.4 White Hispanic/Latino 30DEC2020 C4591001 1084 10841564/ Placebo 12 Male 153 53.1 22.7 White Hispanic/Latino 30DEC2020 C4591001 1084 10841565/ Placebo 14 Female 157 52 21.1 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1084 10841566/ BNT162b2 (30 μg) 15 Male 175 69.5 22.7 Asian Other Non-Hispanic/non- Latino 30DEC2020 C4591001 1084 10841567/ BNT162b2 (30 μg) 14 Female 168.5 54.3 19.1 Asian Other Non-Hispanic/non- Latino 30DEC2020 C4591001 1084 10841568/ Placebo 15 Male 181.5 78.6 23.9 White Hispanic/Latino 30DEC2020 C4591001 1084 10841569/ Placebo 14 Female 161 48.8 18.8 White Hispanic/Latino 30DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 113 FDA-CBER-2022-5812-0224417 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1084 10841570/ Placebo 13 Male 172.6 44.9 15.1 White Hispanic/Latino 30DEC2020 C4591001 1084 10841571/ Placebo 15 Female 164.2 58.3 21.6 Asian Other Non-Hispanic/non- Latino 30DEC2020 C4591001 1084 10841572/ Placebo 13 Female 161.6 56.1 21.5 White Hispanic/Latino 04JAN2021 C4591001 1084 10841573/ BNT162b2 (30 μg) 12 Female 150.6 58 25.6 White Hispanic/Latino 04JAN2021 C4591001 1084 10841574/ BNT162b2 (30 μg) 12 Male 160.4 73.6 28.6 White Hispanic/Latino 04JAN2021 C4591001 1084 10841575/ Placebo 15 Male 168.5 46 16.2 Asian Other Hispanic/Latino 04JAN2021 C4591001 1084 10841576/ BNT162b2 (30 μg) 15 Male 173 62.5 20.9 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1084 10841577/ Placebo 15 Female 159 60 23.7 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1084 10841578/ BNT162b2 (30 μg) 13 Male 150 42.1 18.7 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1084 10841579/ Placebo 13 Female 161 59.2 22.8 White Non-Hispanic/non- Latino 06JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 114 FDA-CBER-2022-5812-0224418 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1084 10841580/ BNT162b2 (30 μg) 12 Female 160 53.5 20.9 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1084 10841581/ Placebo 14 Male 175 63.4 20.7 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1084 10841582/ BNT162b2 (30 μg) 12 Male 154 42 17.7 Asian Other Hispanic/Latino 06JAN2021 C4591001 1084 10841583/ BNT162b2 (30 μg) 15 Female 162.5 77.7 29.4 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1084 10841584/ BNT162b2 (30 μg) 14 Female 158.9 71.2 28.2 White Hispanic/Latino 08JAN2021 C4591001 1084 10841586/ Placebo 15 Male 182 112.3 33.9 White Hispanic/Latino 08JAN2021 C4591001 1084 10841587/ Placebo 12 Male 147.6 31.6 14.5 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1084 10841588/ Placebo 14 Female 153.9 80.6 34 White Hispanic/Latino 08JAN2021 C4591001 1084 10841589/ Placebo 15 Male 169.5 95.6 33.3 White Hispanic/Latino 08JAN2021 C4591001 1084 10841590/ Placebo 15 Male 172 58.8 19.9 White Non-Hispanic/non- Latino 08JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 115 FDA-CBER-2022-5812-0224419 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1084 10841591/ BNT162b2 (30 μg) 12 Female 161 46.7 18 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1084 10841592/ BNT162b2 (30 μg) 14 Female 161 42.2 16.3 Asian Other Non-Hispanic/non- Latino 08JAN2021 C4591001 1084 10841593/ BNT162b2 (30 μg) 12 Male 158.3 45.6 18.2 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1084 10841594/ BNT162b2 (30 μg) 12 Male 169.1 52.8 18.5 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1084 10841595/ Placebo 13 Female 152 56.4 24.4 White Hispanic/Latino 08JAN2021 C4591001 1084 10841596/ Placebo 14 Female 159.1 50.5 20 White Hispanic/Latino 08JAN2021 C4591001 1084 10841597/ Placebo 15 Male 170.6 79.95 27.5 White Hispanic/Latino 08JAN2021 C4591001 1091 10911394/ BNT162b2 (30 μg) 15 Female 174 69.5 23 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1091 10911395/ BNT162b2 (30 μg) 14 Male 171.5 51.5 17.5 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1091 10911396/ Placebo 15 Female 154.9 50.6 21.1 White Non-Hispanic/non- Latino 02DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 116 FDA-CBER-2022-5812-0224420 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1091 10911399/ BNT162b2 (30 μg) 14 Male 182.6 60.5 18.1 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1091 10911400/ Placebo 14 Female 152.6 61.1 26.2 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1091 10911402/ BNT162b2 (30 μg) 12 Female 153.7 48.1 20.4 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1091 10911403/ BNT162b2 (30 μg) 15 Male 166.4 48.2 17.4 Black or African American Non-Hispanic/non- Latino 07DEC2020 C4591001 1091 10911404/ Placebo 13 Female 175.3 86.9 28.3 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1091 10911405/ Placebo 12 Male 157.5 56.7 22.9 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1091 10911406/ BNT162b2 (30 μg) 14 Male 157.5 46.1 18.6 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1091 10911407/ Placebo 12 Male 160.5 45.4 17.6 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1091 10911408/ BNT162b2 (30 μg) 15 Male 174 69.2 22.9 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1091 10911409/ Placebo 14 Female 154.2 43.9 18.5 Asian Non-Hispanic/non- Latino 09DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 117 FDA-CBER-2022-5812-0224421 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1091 10911410/ BNT162b2 (30 μg) 12 Female 150.9 39.4 17.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1091 10911411/ Placebo 15 Male 173.2 54.2 18.1 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1091 10911412/ BNT162b2 (30 μg) 15 Female 162.6 79 29.9 Multiracial Non-Hispanic/non- Latino 09DEC2020 C4591001 1091 10911413/ BNT162b2 (30 μg) 12 Male 160.7 57.1 22.1 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1091 10911414/ BNT162b2 (30 μg) 14 Male 162.3 71.9 27.3 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1091 10911415/ Placebo 15 Female 158.8 52.4 20.8 Asian Other Non-Hispanic/non- Latino 10DEC2020 C4591001 1091 10911416/ BNT162b2 (30 μg) 15 Male 176.5 60.1 19.3 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1091 10911417/ Placebo 13 Female 172.7 59.5 19.9 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1091 10911418/ Placebo 14 Male 160.7 48.6 18.8 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1091 10911419/ BNT162b2 (30 μg) 13 Female 161.3 39.9 15.3 White Non-Hispanic/non- Latino 10DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 118 FDA-CBER-2022-5812-0224422 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1091 10911420/ BNT162b2 (30 μg) 12 Female 130.2 41.7 24.6 White Hispanic/Latino 10DEC2020 C4591001 1091 10911421/ Placebo 15 Male 167 52.2 18.7 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1091 10911422/ BNT162b2 (30 μg) 15 Female 168.9 55.2 19.3 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1091 10911423/ Placebo 14 Female 158.8 48.5 19.2 Black or African American Non-Hispanic/non- Latino 14DEC2020 C4591001 1091 10911424/ Placebo 14 Male 179.1 62.5 19.5 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1091 10911425/ Placebo 12 Female 157.5 53.6 21.6 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1091 10911426/ BNT162b2 (30 μg) 13 Female 167.6 50.6 18 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1091 10911427/ Placebo 12 Male 149.6 36.6 16.4 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1091 10911428/ BNT162b2 (30 μg) 13 Female 152.7 43 18.4 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1091 10911429/ Placebo 15 Male 177.8 74 23.4 White Non-Hispanic/non- Latino 16DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 119 FDA-CBER-2022-5812-0224423 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1091 10911430/ Placebo 13 Female 156.2 44 18 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1091 10911431/ BNT162b2 (30 μg) 13 Male 165.1 71.3 26.2 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1091 10911432/ BNT162b2 (30 μg) 12 Female 144.8 32.4 15.5 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1091 10911433/ Placebo 14 Male 173.2 57.2 19.1 White Hispanic/Latino 17DEC2020 C4591001 1091 10911434/ Placebo 14 Male 160 44.9 17.5 Black or African American Non-Hispanic/non- Latino 17DEC2020 C4591001 1091 10911435/ BNT162b2 (30 μg) 12 Male 163.8 46.1 17.2 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1091 10911436/ BNT162b2 (30 μg) 14 Male 175.3 53.8 17.5 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1091 10911437/ Placebo 13 Male 174 47.5 15.7 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1091 10911438/ BNT162b2 (30 μg) 12 Male 160 51.2 20 Asian Other Non-Hispanic/non- Latino 18DEC2020 C4591001 1091 10911439/ Placebo 14 Male 161.3 50 19.2 White Non-Hispanic/non- Latino 18DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 120 FDA-CBER-2022-5812-0224424 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1091 10911440/ BNT162b2 (30 μg) 13 Female 160 40.6 15.9 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1091 10911441/ Placebo 13 Female 158.1 36.6 14.6 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1091 10911442/ Placebo 15 Female 175.3 71.6 23.3 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1091 10911443/ BNT162b2 (30 μg) 12 Male 154.9 51.1 21.3 Asian Other Non-Hispanic/non- Latino 21DEC2020 C4591001 1091 10911444/ BNT162b2 (30 μg) 15 Male 180.3 68 20.9 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1091 10911445/ Placebo 13 Male 182.9 62 18.5 Asian Other Non-Hispanic/non- Latino 21DEC2020 C4591001 1091 10911446/ BNT162b2 (30 μg) 12 Male 161.3 66.8 25.7 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1091 10911447/ BNT162b2 (30 μg) 15 Male 158.8 48.1 19.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1091 10911448/ Placebo 13 Male 156.2 39 16 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1091 10911449/ Placebo 13 Male 172.7 56.8 19 White Non-Hispanic/non- Latino 22DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 121 FDA-CBER-2022-5812-0224425 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1091 10911450/ Placebo 13 Male 160 51.9 20.3 Multiracial Other Non-Hispanic/non- Latino 22DEC2020 C4591001 1091 10911451/ BNT162b2 (30 μg) 15 Male 179.1 95.3 29.7 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1091 10911452/ Placebo 14 Female 174 76.7 25.3 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1091 10911453/ BNT162b2 (30 μg) 15 Female 153.7 54.6 23.1 Asian Other Non-Hispanic/non- Latino 22DEC2020 C4591001 1091 10911454/ BNT162b2 (30 μg) 14 Male 181.6 62.6 19 Multiracial Other Non-Hispanic/non- Latino 28DEC2020 C4591001 1091 10911455/ Placebo 12 Female 159.3 52.1 20.5 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1091 10911456/ Placebo 13 Female 160 69.5 27.1 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1091 10911457/ BNT162b2 (30 μg) 13 Female 158.8 61 24.2 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1091 10911458/ BNT162b2 (30 μg) 14 Male 165.1 50.2 18.4 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1091 10911459/ Placebo 14 Male 165.1 50.9 18.7 White Non-Hispanic/non- Latino 29DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 122 FDA-CBER-2022-5812-0224426 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1091 10911460/ BNT162b2 (30 μg) 13 Female 164.3 54 20 Black or African American Non-Hispanic/non- Latino 30DEC2020 C4591001 1091 10911461/ Placebo 14 Female 149.9 54 24 Asian Other Non-Hispanic/non- Latino 30DEC2020 C4591001 1091 10911462/ BNT162b2 (30 μg) 15 Male 179.1 95.3 29.7 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1091 10911463/ Placebo 15 Male 182.9 64.7 19.3 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1091 10911464/ BNT162b2 (30 μg) 13 Female 167.6 48 17.1 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1091 10911465/ BNT162b2 (30 μg) 15 Female 164.6 45.9 16.9 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1091 10911466/ Placebo 13 Male 168.9 62.9 22 White Non-Hispanic/non- Latino 11JAN2021 C4591001 1123 11231422/ Placebo 15 Male 187 80.3 23 White Non-Hispanic/non- Latino 01DEC2020 C4591001 1123 11231425/ BNT162b2 (30 μg) 14 Female 167 88.4 31.7 White Non-Hispanic/non- Latino 02DEC2020 C4591001 1123 11231428/ BNT162b2 (30 μg) 12 Male 154 40.5 17.1 White Non-Hispanic/non- Latino 03DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 123 FDA-CBER-2022-5812-0224427 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231431/ Placebo 13 Male 165 51 18.7 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1123 11231432/ BNT162b2 (30 μg) 14 Male 170 63.3 21.9 White Non-Hispanic/non- Latino 04DEC2020 C4591001 1123 11231434/ Placebo 12 Female 160 55.2 21.6 White Hispanic/Latino 07DEC2020 C4591001 1123 11231438/ Placebo 14 Female 162.5 59.1 22.4 American Indian or Alaska Native Hispanic/Latino 08DEC2020 C4591001 1123 11231439/ BNT162b2 (30 μg) 12 Female 166 101 36.7 American Indian or Alaska Native Hispanic/Latino 08DEC2020 C4591001 1123 11231440/ BNT162b2 (30 μg) 13 Male 171.5 79.5 27 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1123 11231441/ Placebo 14 Male 170 77.4 26.8 Black or African American Hispanic/Latino 09DEC2020 C4591001 1123 11231442/ Placebo 12 Male 164 86.5 32.2 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1123 11231443/ BNT162b2 (30 μg) 14 Female 163 61.1 23 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1123 11231445/ Placebo 12 Female 147 36.7 17 White Non-Hispanic/non- Latino 09DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 124 FDA-CBER-2022-5812-0224428 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231446/ BNT162b2 (30 μg) 14 Male 174.5 56 18.4 White Non-Hispanic/non- Latino 09DEC2020 C4591001 1123 11231447/ BNT162b2 (30 μg) 13 Male 149 43.6 19.6 White Non-Hispanic/non- Latino 10DEC2020 C4591001 1123 11231448/ Placebo 13 Male 170 117 40.5 Black or African American Non-Hispanic/non- Latino 11DEC2020 C4591001 1123 11231449/ BNT162b2 (30 μg) 15 Female 135.2 64 35 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1123 11231450/ Placebo 15 Male 179 68.5 21.4 Black or African American Non-Hispanic/non- Latino 11DEC2020 C4591001 1123 11231451/ BNT162b2 (30 μg) 12 Male 164.1 68.9 25.6 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1123 11231452/ Placebo 15 Female 164 58.5 21.8 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1123 11231453/ BNT162b2 (30 μg) 12 Male 167 69.2 24.8 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1123 11231454/ Placebo 15 Female 171 50.8 17.4 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1123 11231455/ BNT162b2 (30 μg) 13 Female 166.5 61.7 22.3 White Non-Hispanic/non- Latino 15DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 125 FDA-CBER-2022-5812-0224429 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231456/ Placebo 13 Female 158.1 58.1 23.2 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1123 11231457/ Placebo 15 Female 158.5 38.6 15.4 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1123 11231458/ BNT162b2 (30 μg) 12 Female 161 62.9 24.3 White Hispanic/Latino 16DEC2020 C4591001 1123 11231459/ BNT162b2 (30 μg) 15 Female 165 75.4 27.7 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1123 11231460/ Placebo 15 Female 164 58 21.6 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1123 11231461/ BNT162b2 (30 μg) 15 Male 201 80.9 20 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1123 11231462/ BNT162b2 (30 μg) 12 Male 157.5 51 20.6 White Non-Hispanic/non- Latino 17DEC2020 C4591001 1123 11231463/ Placebo 14 Female 171 47.9 16.4 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1123 11231465/ Placebo 14 Female 165.5 51.1 18.7 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1123 11231466/ BNT162b2 (30 μg) 13 Female 155 34.9 14.5 White Non-Hispanic/non- Latino 18DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 126 FDA-CBER-2022-5812-0224430 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231467/ Placebo 13 Male 159.2 51.2 20.2 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231468/ Placebo 15 Female 167.5 74.7 26.6 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231469/ BNT162b2 (30 μg) 14 Female 164 64.6 24 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231470/ Placebo 13 Female 159 60.6 24 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231472/ BNT162b2 (30 μg) 15 Female 165 47.4 17.4 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231473/ Placebo 15 Female 163 54 20.3 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231474/ BNT162b2 (30 μg) 12 Female 162.5 61.1 23.1 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231475/ BNT162b2 (30 μg) 14 Male 174 72.5 23.9 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231476/ Placebo 13 Female 164.5 44.5 16.4 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231477/ BNT162b2 (30 μg) 12 Female 148.5 39.9 18.1 White Non-Hispanic/non- Latino 21DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 127 FDA-CBER-2022-5812-0224431 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231478/ Placebo 13 Female 156.5 54.4 22.2 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231479/ Placebo 14 Female 170.5 62.2 21.4 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231481/ BNT162b2 (30 μg) 15 Female 172.5 49.7 16.7 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1123 11231482/ BNT162b2 (30 μg) 13 Male 162.5 51.6 19.5 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1123 11231483/ Placebo 12 Female 167 53.6 19.2 Multiracial Non-Hispanic/non- Latino 22DEC2020 C4591001 1123 11231484/ BNT162b2 (30 μg) 14 Female 158 38.8 15.5 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1123 11231485/ Placebo 13 Female 165 47 17.3 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1123 11231486/ BNT162b2 (30 μg) 14 Female 163.2 53.5 20.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1123 11231487/ Placebo 14 Male 170 72.7 25.2 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1123 11231488/ BNT162b2 (30 μg) 12 Female 159 44.7 17.7 White Non-Hispanic/non- Latino 22DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 128 FDA-CBER-2022-5812-0224432 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231489/ BNT162b2 (30 μg) 13 Male 160 43.8 17.1 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1123 11231491/ Placebo 14 Male 174.1 49.9 16.5 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1123 11231492/ Placebo 15 Male 188 99 28 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1123 11231493/ BNT162b2 (30 μg) 14 Male 184 107.5 31.8 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1123 11231494/ BNT162b2 (30 μg) 13 Female 164.5 51.1 18.9 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1123 11231495/ BNT162b2 (30 μg) 15 Male 192.3 84.7 22.9 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1123 11231496/ Placebo 13 Female 166.2 46.6 16.9 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1123 11231497/ Placebo 13 Male 180 76.1 23.5 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1123 11231499/ Placebo 12 Male 165.5 59.2 21.6 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231500/ BNT162b2 (30 μg) 14 Male 177.6 65.6 20.8 White Non-Hispanic/non- Latino 28DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 129 FDA-CBER-2022-5812-0224433 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231501/ Placebo 12 Female 167 67.1 24.1 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231502/ BNT162b2 (30 μg) 14 Female 176 59.9 19.3 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231503/ Placebo 13 Female 155 38.2 15.9 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231504/ BNT162b2 (30 μg) 15 Male 178 62.7 19.8 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231505/ Placebo 12 Female 164.5 49.9 18.4 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231506/ BNT162b2 (30 μg) 12 Female 160 55.9 21.8 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231507/ BNT162b2 (30 μg) 14 Female 162.5 50.7 19.2 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231508/ BNT162b2 (30 μg) 13 Female 165 51.5 18.9 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1123 11231509/ Placebo 12 Female 161.5 51.4 19.7 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1123 11231510/ Placebo 13 Female 165 52 19.1 White Non-Hispanic/non- Latino 29DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 130 FDA-CBER-2022-5812-0224434 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231511/ BNT162b2 (30 μg) 13 Male 170 57.1 19.8 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231512/ BNT162b2 (30 μg) 13 Female 163.5 52.9 19.8 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231513/ Placebo 12 Male 156 43.7 18 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231514/ Placebo 15 Male 180 60.4 18.6 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231515/ Placebo 14 Male 171.5 56.4 19.2 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231516/ Placebo 13 Male 177 78.7 25.1 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231517/ BNT162b2 (30 μg) 15 Male 177 56.5 18 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231518/ BNT162b2 (30 μg) 15 Male 185 107.1 31.3 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231519/ BNT162b2 (30 μg) 12 Female 154.9 84.1 35.1 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231520/ Placebo 12 Male 160 38.3 15 White Non-Hispanic/non- Latino 30DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 131 FDA-CBER-2022-5812-0224435 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1123 11231521/ BNT162b2 (30 μg) 12 Female 147.3 37.7 17.4 White Non-Hispanic/non- Latino 30DEC2020 C4591001 1123 11231522/ Placebo 15 Male 162.5 40.4 15.3 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1123 11231523/ Placebo 12 Male 155 33.3 13.9 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1123 11231524/ BNT162b2 (30 μg) 14 Male 178 59 18.6 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1123 11231525/ BNT162b2 (30 μg) 14 Female 170 68 23.5 White Non-Hispanic/non- Latino 07JAN2021 C4591001 1123 11231526/ Placebo 14 Female 165 78.2 28.7 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1124 11241236/ Placebo 13 Female 160.02 63.18 24.6 Asian Non-Hispanic/non- Latino 14DEC2020 C4591001 1124 11241238/ BNT162b2 (30 μg) 13 Male 165.1 52.27 19.1 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1124 11241239/ BNT162b2 (30 μg) 12 Male 165.1 36.36 13.3 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1124 11241240/ Placebo 15 Female 167.64 61.36 21.8 White Non-Hispanic/non- Latino 14DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 132 FDA-CBER-2022-5812-0224436 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1124 11241241/ Placebo 13 Male 152.4 50 21.5 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1124 11241242/ Placebo 14 Male 177.8 97.73 30.8 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1124 11241243/ BNT162b2 (30 μg) 13 Male 165.1 94.09 34.4 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1124 11241244/ BNT162b2 (30 μg) 12 Female 152.4 42 18 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1124 11241245/ BNT162b2 (30 μg) 14 Female 162.56 54.55 20.6 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1124 11241246/ BNT162b2 (30 μg) 12 Female 152.4 43.64 18.7 White Non-Hispanic/non- Latino 15DEC2020 C4591001 1124 11241247/ Placebo 13 Male 162.56 75 28.3 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1124 11241248/ Placebo 13 Female 152.4 50 21.5 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1124 11241249/ BNT162b2 (30 μg) 14 Male 162.56 43.64 16.5 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1124 11241250/ Placebo 12 Female 157.48 43.18 17.4 White Non-Hispanic/non- Latino 17DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 133 FDA-CBER-2022-5812-0224437 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1124 11241251/ BNT162b2 (30 μg) 15 Female 154.94 52.73 21.9 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1124 11241252/ Placebo 13 Male 147.32 38.64 17.8 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1124 11241253/ BNT162b2 (30 μg) 12 Female 160.02 40 15.6 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1124 11241254/ BNT162b2 (30 μg) 14 Male 172.72 50 16.7 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1124 11241255/ Placebo 13 Female 152.4 49.55 21.3 White Non-Hispanic/non- Latino 18DEC2020 C4591001 1124 11241256/ Placebo 12 Male 154.94 44.09 18.3 White Non-Hispanic/non- Latino 21DEC2020 C4591001 1124 11241257/ Placebo 13 Female 149.86 37.27 16.6 White Non-Hispanic/non- Latino 22DEC2020 C4591001 1124 11241258/ Placebo 14 Female 162.56 73 27.6 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1124 11241259/ BNT162b2 (30 μg) 13 Female 165.1 72.09 26.4 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1124 11241260/ BNT162b2 (30 μg) 13 Male 162.56 75.09 28.4 White Non-Hispanic/non- Latino 23DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 134 FDA-CBER-2022-5812-0224438 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1124 11241261/ BNT162b2 (30 μg) 13 Male 149.86 40.91 18.2 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1124 11241262/ BNT162b2 (30 μg) 15 Female 175.26 61 19.8 White Non-Hispanic/non- Latino 23DEC2020 C4591001 1124 11241263/ Placebo 13 Female 162.56 57.27 21.6 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1124 11241264/ Placebo 14 Male 154.94 42.82 17.8 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1124 11241265/ BNT162b2 (30 μg) 14 Female 165.1 56.82 20.8 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1124 11241266/ BNT162b2 (30 μg) 12 Male 147.32 39.09 18 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1124 11241267/ Placebo 12 Male 149.86 39.09 17.4 White Non-Hispanic/non- Latino 29DEC2020 C4591001 1124 11241268/ Placebo 14 Female 157.48 63.64 25.6 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1124 11241269/ BNT162b2 (30 μg) 15 Male 177.8 54.45 17.2 White Non-Hispanic/non- Latino 04JAN2021 C4591001 1124 11241270/ Placebo 15 Female 154.94 54.55 22.7 White Non-Hispanic/non- Latino 05JAN2021 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 135 FDA-CBER-2022-5812-0224439 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1124 11241271/ BNT162b2 (30 μg) 12 Male 167.64 57.36 20.4 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1124 11241272/ Placebo 12 Male 142.24 37.27 18.4 White Non-Hispanic/non- Latino 05JAN2021 C4591001 1124 11241273/ BNT162b2 (30 μg) 12 Female 149.86 48.36 21.5 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1124 11241274/ Placebo 15 Male 167.64 47.55 16.9 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1124 11241275/ BNT162b2 (30 μg) 13 Male 161.29 41.18 15.8 White Non-Hispanic/non- Latino 08JAN2021 C4591001 1125 11251241/ BNT162b2 (30 μg) 15 Female 165.1 69.09 25.3 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1125 11251242/ Placebo 15 Female 168.9 57.1 20 White Non-Hispanic/non- Latino 07DEC2020 C4591001 1125 11251244/ Placebo 13 Female 152.4 41.36 17.8 White Non-Hispanic/non- Latino 08DEC2020 C4591001 1125 11251246/ BNT162b2 (30 μg) 13 Female 170.18 91.36 31.5 White Hispanic/Latino 10DEC2020 C4591001 1125 11251248/ Placebo 15 Male 180.34 75 23 White Non-Hispanic/non- Latino 11DEC2020 090177e1988b7710\Final\Final On: 09-Nov-2021 04:11 (GMT) Page 136 FDA-CBER-2022-5812-0224440 16.2.4 Listing of Demographic Characteristics – All Subjects 12 Through 15 Years of Age Subject/ Vaccine Group (as Randomized) Age (Years) Sex Height (cm)Weight (kg) Body Mass Index (BMI) (kg/m2) Race Racial Designation Ethnicity Informed Consent Date (Screening) C4591001 1125 11251249/ Placebo 14 Female 170.18 64.55 22.2 White Non-Hispanic/non- Latino 11DEC2020 C4591001 1125 11251250/ BNT162b2 (30 μg) 12 Male 153.67 60 25.4 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1125 11251251/ BNT162b2 (30 μg) 13 Female 167.6 64.8 23.1 White Non-Hispanic/non- Latino 14DEC2020 C4591001 1125 11251252/ BNT162b2 (30 μg) 13 Male 170.18 72.73 25.1 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1125 11251253/ Placebo 12 Male 162.56 47.73 18 White Non-Hispanic/non- Latino 16DEC2020 C4591001 1125 11251254/ Placebo 13 Male 172.72 56.36 18.9 White Non-Hispanic/non- Latino 28DEC2020 C4591001 1125 11251255/ BNT162b2 (30 μg) 12 Male 156.21 55.45 22.7 White Non-Hispanic/non- Latino 06JAN2021 C4591001 1126 11261229/ BNT162b2 (30 μg) 14 Male 172.7 55.5 18.6 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1126 11261230/ BNT162b2 (30 μg) 13 Male 175.3 68.4 22.3 White Non-Hispanic/non- Latino 30NOV2020 C4591001 1126 1126123 …[truncated]